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THE CONTIBUTION OF POLY(ADP-RIBOSE)POLYMERASE-1 ACTIVITY IN
THE NUCELOTIDE EXCISION REPAIR PATHWAY

By
Brenee S. King

B.S. Chemistry, University of California, Santa Barbara
PhD, Biomedical Sciences, University of New Mexico

ABSTRACT
Exposure to ultraviolet radiation (UVR) promotes the formation of UVR-induced,
DNA helix distorting photolesions such as (6-4) pyrimidine-pyrimidone photoproducts
(6-4 PPs) and cyclobutane pyrimidine dimers (CPDs). Effective repair of such lesions by
the nucleotide excision repair (NER) pathway is required to prevent DNA mutations and
chromosome aberrations. Poly(ADP-ribose)polymerase-1 (PARP-1) is a zinc-finger
protein with well documented involvement in base excision repair (BER). PARP-1 is
activated in response to DNA damage and catalyzes the formation of poly(ADP-ribose)
subunits (PAR) that assist in the assembly of DNA repair complexes at sites of damage.
In this dissertation, I present evidence for PARP-1 contributions to NER, extending the
knowledge of PARP-1 function in DNA repair beyond the established role in BER.
Silencing the PARP-1 protein or inhibiting PARP activity leads to retention of UVRinduced photolesions in vitro and in vivo. PARP activation following UVR exposure
promotes association between PARP-1 and XPC, a central protein in lesion recognition in
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the global genomic arm of NER. Additionally, PARP activation following UVR
promotes association with XPA, an essential protein in NER that is involved in DNA
damage verification and stability of the preincision complex. Both proteins are predicted
to contain the well defined 25 amino acid PAR binding sequence. Administration of
PARP inhibitors confirms that PAR facilitates PARP-1 association with XPA and XPC in
whole cell extracts as well as in isolated chromatin complexes; and illustrates the
importance of the PAR binding sequence in PARP-1’s interaction with NER proteins.
Furthermore, inhibition of PARP activity decreases UVR-stimulated XPA and XPC
chromatin association. These data not only illustrate that these relationships occur in the
meaningful context for NER, but they also demonstrate a novel role for PAR as a
potential modulator of NER proteins. Overall, these results provide a mechanistic link for
PARP activity in the repair of UVR-induced photoproducts which could potentially be
useful in the development of new combinations of cancer chemotherapy drugs.
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CHAPTER 1
Introduction
1.1.

Structures of the skin

The skin is our first line of defense from environmental insults. It has evolved to
perform an array of protective functions such as preventing water loss, resisting
mechanical stress and participating in immunological responses (Simpson et al., 2011).
The skin is the largest organ in the body and consists of three layers: the epidermis,
dermis and hypodermis. The dermis consists of connective tissue, and is the location of
hair follicles, sweat glands and blood vessels (Fuchs and Raghavan, 2002) . Located
within the dermis, there are several appendages that contain niches of stem cells,
including the bulge region of the hair follicle, and sebaceous glands. The dermis and the
epidermis are separated by a basement membrane, which is composed of extracellular
matrix proteins such as collagen and laminin. Keratinocytes are squamous epithelial cells
and constitute approximately 95% of the cells found in the epidermis. The remainder of
epidermal cells includes melanocytes, Langerhans cells and Merkel cells.
The epidermis is a stratified epithelium comprised of several layers. The outermost
layer is the stratum corneum (SC), followed by the stratum granulosum (SG) and stratum
spinosum (SS) and the inner most layer of the epidermis is the stratum basale (SB) layer
(Fuchs and Raghavan, 2002). Keratinocytes differentiate and migrate outwards, from the
stratum basale, to replace cells that are shed from the body’s surface. A subset of basal
cells meet the universal definition of a stem cell, a cell that can divide to produce both
daughter stem cells and cells that go on to differentiate. Those cells that are not
1

considered to be stem cells are rapidly dividing progenitor cells, referred to as transit
amplifying cells, that undergo a limited number of divisions before they withdraw from
the cell cycle (Fuchs and Raghavan, 2002). Initially it was believed that intrafollicular
stem cells were progenitor cells of transit amplifying cells (Watt et al., 2006). Current
studies support a model of the committed progenitor cell, that proliferates like a stem cell
but is committed to terminal differentiation similar to a transit amplifying cell (Clayton et
al., 2007; Jones and Simons, 2008). Once cells commit to terminal differentiation they
detach from the basement membrane and migrate upwards toward the surface of the skin.
Cells within the stratum spinosum exit the cell cycle, grow larger and establish
additional intercellular connections. As cells move further upward into the stratum
granulosum they become flattened and assemble a water-impermeable cornified envelope
underlying their plasma membranes (Fig. 1.1) (Simpson et al., 2011).

FIGURE 1.1. Layers of the epidermis. The outermost layer of the epidermis is the stratum
cornea (SC), followed by the stratum granulosum (SG), stratum spinosum (SS), and lastly the
stratum basale (BL) which is layered upon the basement membrane.

2

Lastly, the stratum corneum forms a physical barrier made of a continuous sheet of
protein-enriched cells known as corneocytes. At this stage, keratinocytes have completed
their differentiation program and lack nuclei and cytoplasmic organelles (Koster, 2009;
Proksch et al., 2008). Once constructed, the epidermis is maintained through continual
stratification and differentiation of keratinocytes. This constant state of equilibrium
allows the epidermis to replenish itself every two weeks throughout life (Fuchs and
Raghavan, 2002).

1.2.

Skin Cancer

Sunlight is essential to life on earth. What reaches the earth’s surface is a frequency
spectrum of electromagnetic radiation composed of visible and ultraviolet light (von
Thaler et al., 2010). Ultraviolet radiation (UVR) is divided into long wavelength UVA
(315-400 nm), medium wavelength UVB (280-315 nm) and short wavelength UVC
(<280 nm). As UVR enters the earth’s atmosphere, the entire UVC spectrum is absorbed
by the ozone layer, in addition to the majority of UVB. Of the UVR that reaches the
earth’s surface about 90-99 % is UVA (Narayanan et al., 2010), depending on cloud
coverage and atmospheric conditions. Energy from UV radiation can be absorbed by
cellular proteins and DNA and can cause mutagenic lesions. If these lesions are not
repaired properly they may contribute to the formation of cancer.
Skin cancer is the most common type of cancer in humans, and exposure to UVR
radiation is thought to be the main etiological factor (Narayanan et al., 2010; Zhang et
al., 2011). Skin cancers are broadly divided into melanoma and nonmelanoma skin
cancers (NMSC). Nonmelanoma skin cancers are further categorized into squamous cell
carcinoma (SCC) and basal cell carcinoma (BCC).
3

1.2.1. Nonmelanoma skin cancers
It is estimated that 2-3 million cases of NMSC occur world-wide each year
(Narayanan et al., 2010). BCC account for 80-85% of NMSC and have been associated
with intense acute sun exposure and sunburns before the age of 20 and development of
tumors 10 to 50 years after sun damage (Roewert-Huber et al., 2007). In about 80% of
cases it is located on the face and neck (Chinem and Miot, 2011). No precursor lesions
have been described for BCC and the source cells remain controversial. Even though the
tumor cells resemble those in the basal layer of the epidermis, there is evidence that they
are derived from immature pluripotent cells of interfollicular epidermis and those in the
outer sheath of the hair follicle (Youssef et al., 2010). BCC is locally invasive and has a
low metastatic potential.
SCC accounts for about 10-15% of all NMSC and may invade other tissues and cause
death. Similar to BCC, SCC is more frequent on sun-exposed areas of the skin such as the
head, neck and forehead regions. In contrast to BCC, SCC is often associated with
cumulative rather than acute exposure to UVR (Rass and Reichrath, 2008). Interfollicular
epidermal basal keratinocytes are the assumed precursor cells for SCC and the recognized
precancerous progenitor is actinic keratosis (Alam and Ratner, 2001; Callen et al., 1997).
While this precancerous condition can progress to SCC, with one study measuring risk at
1:1000 per year (Marks et al., 1988), it can also be reversible (Frost et al., 2000).

1.2.2. Melanoma
Melanoma, while being the least common form of skin cancer, is the most serious and
carries the highest mortality rate. Melanoma represents about 3% of all skin cancers in
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the United States but accounts for nearly 75% of all skin cancer deaths (Jerant et al.,
2000; Narayanan et al., 2010). Melanoma derives from the malignant transformation of
cutaneous melanocytes. These cells reside in the basal layer of the epidermis and are in
contact with keratinocytes. Melanocytes represent about 1-2% of epidermal cells
(Maddodi and Setaluri, 2008). Melanocytes produce and distribute the photoprotective
chromophore melanin which is able to absorb UVR and visible light. The production of
melanin varies amongst skin types and is thought to be a contributing factor in
melanomagenesis. This is partially revealed in the different incidence rates of various
ethnic groups. The incidence rate of melanoma is 16 times greater in Caucasians than
African Americans. When compared to Hispanics, the incidence rate is 10 times greater
for Caucasians (Gloster and Neal, 2006).
Other factors to consider in the development of skin cancer are disease states due to
deficiencies in DNA repair. Xeroderma pigmentosum (XP) is a rare autosomal recessive
disorder of DNA repair proteins, XP complementation groups A-G. Some of the clinical
traits of this disease are photosensitivity, actinic damage of the skin and cancer of UVRexposed areas of the skin (DiGiovanna and Kraemer, 2012). XP patients have a higher
risk of developing skin cancer. For children less than 20 years of age, there is a 10,000fold increase in the frequency of NMSC and a 2,000-fold increase in melanoma
(Bradford et al., 2011). Patients with cockayne syndrome (CS), a disease associated with
mutations in cockayne syndrome A (CKN1/CSA) or cockayne syndrome B
(CKN2/ERCC6/CSB) repair proteins, are sun sensitive and deficient in removal of UVRinduced lesions, but compared to individuals with XP, they are not significantly prone to
skin cancer. Also, half of trichothiodystrophy (TTD) patients who have mutations in
5

repair genes XPD, XPB or TTDA are photosensitive (Bergoglio and Magnaldo, 2006).
Together, these diseases highlight the importance of DNA repair proteins and their ability
to remove damaged DNA.

1.3.

DNA damage following UV exposure

Overall, a fundamental commonality to the development of melanoma and nonmelanoma skin cancer is exposure, both in duration and intensity, to UVR. Energy from
UVR is commonly absorbed by cellular proteins and can induce various forms of DNA
damage.

1.3.1. UVA damage
Approximately 90-99% of UVA light reaches the earth’s surface. It is long
wavelength and low energy light which allows it to penetrate deep into the skin (Timares
et al., 2008). This penetration is deep enough to reach regenerative cellular compartments
in the basal layer and stem cell niche. UVA is estimated to contribute to 10-20% of
sunlight-induced carcinogenesis (Besaratinia et al., 2008). The effects of UVA exposure
on DNA damage are largely indirect. UVA is mainly absorbed by chromophores,
endogenous or exogenous photosensitizers, as opposed to DNA. The excited sensitizers
can undergo either charge transfer to DNA or transfer energy to oxygen, leading to the
formation of reactive oxygen species (Douki et al., 1999). Reactive oxygen species
(ROS) is a collective term, which includes oxygen radicals (superoxide (O2-), hydroxyl
(OH), peroxyl (RO2) and alkoxyl (RO)). ROS also includes nonradicals (HOCl,
peroxynitite (ONOO-), singlet oxygen (1O2) and H2O2) that are oxidizers or easily
converted to radicals (Guetens et al., 2002). Guanine is a major target of ROS because it
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exhibits a low ionization potential which allows it to behave as a sink for the positive
charges that migrate through the DNA double helix (Douki et al., 2003). Following UVA
exposure reactive singlet oxygen can react with guanine forming 8-oxo-7,8-dihydro-2’deoxyguanosine (8-oxo-dG) (Cadet et al., 2005; Pfeifer et al., 2005). Additionally,
exposure to UVA can generate single strand breaks (SSBs). These are discontinuities in
one strand of the DNA double helix and are usually accompanied by a damaged 5’ and/or
3’-end at the site of the break (Caldecott, 2008).
If these SSBs are not repaired during the G1 phase of the cell cycle they can generate
double strand breaks (DSBs) during the S-phase which could then result in chromosome
aberrations including amplification, deletions or translocations (Wischermann et al.,
2008). UVA-induced mutations are commonly G to T transversions and are
predominately found at the basal layer of the epidermis, thereby supporting a role for
UVA exposure in skin photocarcinogenesis (Besaratinia et al., 2008; Drobetsky et al.,
1995; Huang et al., 2009; Pfeifer et al., 2005).
For some time now, studies have demonstrated a role for UVA in the generation of
cyclobutane pyrimidine dimers (CPDs) which are traditionally thought to be formed by
exposure to UVB (Freeman et al., 1987; Freeman et al., 1989; Young et al., 1998). The
initial mechanism by which UVA was thought to produce thymine dimers was through
photosensitization. UVA irradiation in the presence of chromophores induced CPDs
through triplet energy transfer, but the absorbing chromophore had not been identified,
leaving the exact mechanism incomplete (Charlier and Helene, 1972; Douki et al., 2003).
Recently, Mouret et al. showed there were no cellular photosensitizers involved in UVAinduced CPDs, but proposed a direct mechanism of action for the formation of these
7

lesions (Mouret et al., 2010). These results suggest that photoprotection against UVR
should include complete blockage of UVA radiation.

1.3.2. UVB damage
While only a small portion (1-10%) of UVB reaches the earth’s surface it is by far the
most carcinogenic wavelength. One of the major reasons for the carcinogenicity of UVB
(280-315nm) is that this wavelength range is near the absorption maximum of DNA (260
nm) (Vink and Roza, 2001). This leads to the formation of several photolesions such as
cyclobutane pyrimidine dimers (CPDs) and pyrimidine (6-4) pyrimidone photoproducts
(6-4 PPs). The cyclobutane rings of CPDs are formed between the 5,6 bonds of adjacent
pyrimidine bases while 6-4 PPs arise from a rearrangement of bases and contain a stable
single bond between position 6 and position 4 of two adjacent pyrimidine bases (Batista
et al., 2009; Pfeifer and Besaratinia, 2011). 6-4 PPs that absorb around 320 nm are able to
photoisomerize into another photolesion known as Dewar valance isomers (Cadet et al.,
2005; Perdiz et al., 2000).
The common mutations associated with UVB exposure are C to T or CC to TT
tandem base substitutions where C to T transitions can be induced by both CPDs and 6-4
PPs. CPDs are of concern for carcinogenesis due to their relatively high abundance, slow
repair and known mutagenicity (You et al., 2001). Less is known regarding the
mutagenicity of 6-4 PPs. Studies with plasmids containing site-specific lesions have
shown 6-4 PPs to be more mutagenic than CPDs which may be due to the strong helix
distorting potential of this lesion. However, this characteristic also results in more
efficient repair of 6-4 PPs, thus adding to the uncertainty of its contribution to
carcinogenesis (Batista et al., 2009; Ikehata and Ono, 2011).
8

The presence of CPDs or 6-4 PPs in the DNA double helix can result in physical
blockage of proteins which disturbs essential processes such as replication or
transcription. If damaged DNA is left unrepaired or misrepaired in the process, mutations
can form and promote carcinogenesis. DNA repair mechanisms are a way for cells to
counteract the effects of damaged DNA.

1.4.

DNA excision repair pathways
Over the course of a given day there are numerous forms of DNA damage that

occur in cells. There are an estimated 103-105 damaging events/mammalian cell/day
(Prasad et al., 2011) which reveals the dynamic state of DNA. As such, cells have
developed a multitude of repair mechanisms to maintain DNA integrity.

1.4.1. Base excision repair
Single base lesions or strand breaks are the most common form of DNA damage
to occur throughout the genome. DNA bases are commonly modified by oxidation (i.e. 8OHdG), alkylation or deamination by exogenous damaging agents (i.e. arsenic). These
types of damages result in small, non-helix distorting lesions which are repaired by the
base excision repair pathway (BER). BER is divided into two sub pathways that are
differentiated by repair patch size and enzymes involved (Fig. 1.2). Short-patch BER
removes a single damaged nucleotide whereas long patch BER replaces two or more
damaged nucleotides (Almeida and Sobol, 2007; Prasad et al., 2011). The majority of
repair is thought to occur by the short patch repair pathway. Both sub pathways of BER
involve an initial step that includes recognition and excision of the altered base by lesionspecific DNA glycosylases (Jacobs and Schar, 2012). The base removal by DNA
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glycosylases generates an apurinic/apyrimidinic site (AP site) in the DNA which is
further processed by AP endonucleases. The pathway continues with end processing
which readies the site for ligation. Next, DNA polymerases participate in gap filling
which is followed by the work of flap endonucleases and lastly nick-sealing performed
by DNA Ligases (Almeida and Sobol, 2007; Caldecott, 2008).
An additional protein involved in the overall orchestration of BER is X-ray repair
cross-complementing protein 1 (XRCC1). XRCC1 has no known enzymatic activity but
is essential in DNA repair. XRCC1-deficient mice are embryonic lethal and mutant cells
with no functional XRCC1 are hypersensitive to a wide range of DNA damaging agents

FIGURE 1.2. Base excision
repair
pathway
(BER).
Simplified schematic of BER. The
pathway begins with initiation by
glycoylases followed by entry of
AP endonucleases and strand
scission. End processing is then
followed by entry of DNA
polymerase and gap filling. Lastly
there is religation by XRCC1 and
DNA Ligase III.
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including alkylating agents, reactive oxygen species and ionizing radiation, thus showing
a role for this protein in DNA repair pathways (Tebbs et al., 1999; Thompson et al.,
1982; Thompson et al., 1990). In addition, XRCC1 interacts with most components
within the BER short-patch pathway and within this context, acts as a scaffolding protein
(Kubota et al., 1996; Marintchev et al., 1999; Rice, 1999). The first XRCC1 partner to be
discovered was DNA Ligase III (Caldecott et al., 1994; Caldecott et al., 1995). The two
isoforms of DNA Ligase III (α and β) differ in their C-termini and as such, XRCC1 only
interacts with DNA Ligase IIIα. These two proteins interact through their respective
BRAC1 C-terminus-like motifs (BRCT) located in each of their C-termini (Mackey et al.,
1997; Nash et al., 1997; Taylor et al., 1998). Furthermore, this interaction has functional
consequences. Cells lacking XRCC1 display a five-fold decrease of DNA Ligase III
polypeptide and its activity (Caldecott et al., 1995; Ljungquist et al., 1994; Shen et al.,
1998). Another key protein that interacts with XRCC1 is poly(ADP-ribose)polymerase-1
(PARP-1). Masson et al. identified this interaction using the two-hybrid system and
further confirmed that this interaction occurred via the BRCT domains within each
respective protein (Masson et al., 1998). Additional studies show that XRCC1 interacts
with DNA gap tailoring proteins such as APE1, pol β, PNKP and Tdp1 (Almeida and
Sobol, 2007; Lan et al., 2004; Plo et al., 2003; Whitehouse et al., 2001).

1.4.2. Nucleotide excision repair
In addition to the small lesions repaired by BER there are also large, bulky, helixdistorting lesions caused by chemical agents (i.e. benzo(a)pyrene), cross-linking agents
(i.e. cisplatin) or exposure to UVR that are repaired by the nucleotide excision repair
pathway (NER). This is a versatile repair pathway with the ability to remove a multitude
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of lesions. There are two sub pathways within NER, transcription coupled repair (TCNER) and global genomic repair (GG-NER). TC-NER repairs lesions within
transcriptionally active regions, while GG-NER repairs lesions over the entire genome.
These two pathways differ in their recognition steps (Fig. 1.3). Within TC-NER, lesions
are initially recognized when the transcription machinery, RNA pol II, becomes stalled at
lesions and is subsequently displaced by cockanye syndrome proteins (CSB) (Fousteri
and Mullenders, 2008; Rastogi et al., 2010; Tornaletti, 2009). The current consensus
regarding recognition of lesions in GG-NER centers on the xeroderma pigmentosum
complementation group C (XPC) protein (Rechkunova et al., 2011). This protein is part
of a stable heterotrimeric complex which includes hHR23A or hHR23B (S. cerevisiae
RAD23p homologs) and centrin 2 (Kamionka and Feigon, 2004; Sugasawa, 2008) and is
essential for GG-NER initiation in in vitro and in intact cells (Sugasawa et al., 1998;
Volker et al., 2001). XPC is able to detect strongly helix-distorting lesions with high
affinity toward bubble structures and 6-4 PPs (Hey et al., 2002). Additionally, UVdamaged DNA binding protein (UV-DDB) participates in damage recognition (Nishi et
al., 2009; Sugasawa, 2011). UV-DDB is a heterodimer comprised of DDB1/p127 and
DDB2/p48 that tightly binds to UV-irradiated DNA (Protic et al., 1989). DDB2
preferentially recruits XPC to CPDs through a direct physical interaction (Fitch et al.,
2003; Moser et al., 2005; Rastogi et al., 2010; Sugasawa et al., 2005).
Following lesion recognition, all subsequent steps are common to TC-NER and
GG-NER pathways (Fig.1.3).
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FIGURE 1.3. Nucleotide excision repair pathway (NER). Schematic depicting the molecular
mechanisms of the two sub pathways of NER, global genomic repair (GG-NER) and transcription
coupled repair (TC-NER) (Rastogi et al., 2010).
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The next protein to be recruited is the ten-subunit complex TFIIH. This multiprotein
complex contains two ATP-dependent DNA helicases, p89/XPB and p80/XPD, that
contain opposite polarities (Schultz et al., 2000; Thomas and Chiang, 2006). XPB
unwinds double stranded DNA along the 3’ to 5’ end while XPD is a 5’ to 3’ helicase that
tracks along the DNA stalling as it encounters lesions, confirming the presence of
chemical alterations in the DNA (Fagbemi et al., 2011; Fan et al., 2006; Fan et al., 2008).
The combined effect of these proteins leads to an opened DNA structure and the entrance
of XPA, replication protein A (RPA) and XPG, and the formation of the preincision
complex (Rechkunova et al., 2011). XPA is a small 36 kDa Zn-binding protein that has
high affinity for kinked rather than damaged DNA. This observation led to the hypothesis
that XPA interacts with intermediate DNA structures subsequent to DNA recognition
(Camenisch et al., 2006; Missura et al., 2001). Since XPA binds RPA (Ikegami et al.,
1998; Li et al., 1995), TFIIH (Li et al., 1998; Park et al., 1995) and ERCC1, it is thought
to assist in the correct positioning of the repair factors and allow for proper dual incision.
RPA is a trimeric protein that binds to single-stranded DNA. It is the only preincision
factor that is also found with postincision proteins suggesting that it might protect the
undamaged strand from nuclease attack (Hermanson-Miller and Turchi, 2002; Overmeer
et al., 2011). At its initial entrance, XPG fulfills a structural role. It stabilizes the
preincision complex, generating an open-stable complex. At this point in the repair
process, XPG has little to no catalytic activity and full activity is only revealed once the
ERCC1-XPF complex has made the 5’ incision. This allows for the correct polarity
required for the incision 3’ to the lesion in NER (Fagbemi et al., 2011; Scharer, 2008).
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ERCC1-XPF are the last factors to join the preincision complex and are recruited
through an interaction with XPA (Croteau et al., 2008; Orelli et al., 2010). Following
dual incision an oligonucleotide of 24-32 nucleotides in length, containing the lesion, is
released. The resulting gap is filled by DNA polymerase δ, ε or κ (Ogi et al., 2010) and
finally the nick is sealed by DNA ligase I or III/XRCC1 , restoring the DNA back to its
original form (Moser et al., 2007).

1.5.

Aspects of PARP-1 function

Poly(ADP-ribose)polymerases (PARPs) are an ancient family of enzymes. This
family of proteins contains 18 family members, the most studied being PARP-1. PARP-1
is a 113 kDa protein and is the most abundant family member, with an average of 106
molecules/cell (Ludwig et al., 1988). It is a chromatin associated enzyme that is involved
in many cellular processes including DNA repair, cell cycle control, apoptotic signaling,
and transcriptional regulation (D'Amours et al., 1999; Schreiber et al., 2006). The PARP1 protein has three major domains: the DNA binding domain (DBD, residues 1-374), the
automodification domain (residues 375-525) and the catalytic domain (residues 5261014) (Fig. 1.4) (Langelier et al., 2008).

FIGURE 1.4. Functional domains of human PARP-1. Schematic depicting the three main segments
of PARP-1: DNA binding domain, containing three zinc finger domains, automodification domain and
catalytic domain (Langelier et al., 2008).
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The DBD is located in the N terminus of the PARP-1 protein. It contains two zincfingers that recognize damaged DNA. These zinc fingers are unique in that they
recognize altered DNA structures rather than specific sequences (Clark et al., 2012;
Eustermann et al., 2011). A recent low-resolution structure of the N-terminal half of
PARP-1 revealed structural flexibility in the form of hinges connecting the two zinc
fingers with the third zinc finger (Lilyestrom et al., 2010). These data supports the notion
of PARP-1’s third zinc finger being able to couple the DNA binding and catalytic
activities of PARP-1 (Langelier et al., 2010; Langelier et al., 2008; Tao et al., 2008). The
automodification domain contains a BRCT domain that is thought to assist in protein:
protein interactions. The BRCT domain also contains glutamic acid residues that act as a
binding motif for poly(ADP-ribose) (PAR) (Desmarais et al., 1991; Hassa and Hottiger,
2008). Lastly, all PARP members contain a highly conserved 50 amino acid catalytic
domain (Ame et al., 2004) which is located at the C-terminus of PARP-1.

1.5.1. Poly(ADP-ribose) (PAR)
Following DNA damage, PARP-1 binds to altered DNA structures which activate
its catalytic activity by 500-fold thereby producing poly(ADP-ribose) subunits (PAR)
(Gagne et al., 2006; Malanga and Althaus, 2005). PARP-1 uses NAD+ as a substrate to
form PAR. NAD+/NADH is one of the most versatile biomolecules because it can be
used as a coenzyme as well as a substrate for ADP-ribosoyl transfer reactions. PAR is
covalently transferred onto glutamic acid, aspartic acid, or lysine residues of target
proteins (‘acceptors’) followed by the successive addition of subunits (Burkle, 2005).
PARP-1 catalyzes more than 90% of PAR that occurs following DNA damage (Andrabi
et al., 2008). The main acceptor of PAR is PARP-1 itself resulting in automodification
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(Alvarez-Gonzalez and Jacobson, 1987; Satoh and Lindahl, 1992) and subsequent release
from DNA. PAR modifies additional substrates including proteins involved in chromatin
structure, DNA synthesis, DNA repair, transcription and the cell cycle (Malanga and
Althaus, 2005). PAR subunits undergo elongation at the 2’-OH of the mono(ADP-ribose)
and can subsequently branch off at the 2’’-OH of the ribose moiety. Chain lengths on
acceptor proteins can reach up to 200 ADP-ribose units (Burkle, 2005). The net effect of
adding PAR subunits is an overall negative charge and drastic change to the properties of
the acceptor protein. Additionally, PAR formation in response to DNA damage has been
reported to serve other purposes: (1) modification of histone tails leading to relaxation of
chromatin fibers and increased access to breaks (2) signaling the extent of DNA damage
which can result in cell death or repair and (3) assistance in the recruitment of DNA
repair factors (Schreiber et al., 2006). PAR production is an important signal to determine
response to DNA damage. Minimal damage leads to PARP stimulation and nuclear
accumulation of PAR which then assists DNA repair pathways and leads to an overall
cytoprotective effect. On the other hand, too much damage leads to excessive PARP-1
activation and cellular depletion of NAD+ stores which can result in cell death through
necrotic and apoptotic pathways (Heeres and Hergenrother, 2007; Woodhouse and
Dianov, 2008). PARP activation also leads to a unique form of cell death which involves
PAR and the nuclear translocation of apoptosis inducing factor (AIF) from the
mitochondria. This PARP-1 dependent cell death pathway is called parthanatos and its
morphological features include shrunken and condensed nuclei, membrane disintegration,
and sensitivity to propidium iodide within a few hours of onset (Andrabi et al., 2008;
Wang et al., 2009).
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There are three main PAR-binding motifs responsible for mediating associations
between PAR and acceptor proteins. One PAR binding motif is a highly conserved
domain known as the ‘macro domain’ of approximately 130-190 amino acid residues.
This motif is present in several PARP family members such as PARP-9, PARP-14 and
PARP-15 (Han et al., 2010; Karras et al., 2005). Another PAR-binding motif is known as
the PBZ domain. This domain is a putative C2H2 zinc-finger and has been identified in
the checkpoint protein CHFR (checkpoint protein with forkhead-associated and RING
domains) and the DNA damage response protein APLF (aprataxin PNK-like factor)
(Ahel et al., 2008; Li et al., 2011). The best characterized PAR-binding motif contains
approximately 20-25 amino acids with an N-terminal basic amino acid cluster followed
by hydrophobic residues interspersed with basic amino acids. This motif has been
identified in several of the core histones, p53, cyclin-dependent kinase inhibitor 1 (p21),
XRCC1 and other proteins including XPA (Malanga et al., 1998; Pleschke et al., 2000;
Schmitz et al., 1998). The presence of the well characterized PAR-binding motif in
various groups of proteins emphasizes the versatility of this modification. In the case of
DNA repair pathways, this motif is important in mediating protein interactions (Malanga
and Althaus, 2005; Masson et al., 1998).

1.5.2. Poly(ADP-ribose) glycohydrolase (PARG)
Since PARP activity and the formation of PAR are important in numerous cellular
processes, it is not surprising that PARP’s enzymatic activity is tightly regulated. The
primary protein involved in the removal of PAR subunits from modified proteins is
poly(ADP-ribose) glycohydrolase (PARG). PARG contains both endo- and exoglycosidase activity (Bonicalzi et al., 2005). Another protein, ADP-ribosyl protein lyase
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removes the proximal ADP-ribosyl subunit bound to the protein (Oka et al., 1984). To
date, only one PARG gene has been detected in mammals which encods three cDNAs
that generate 3 isoformes, 110 kDa, 102 kDa and 99 kDa, with the major product being
the 110 kDa isoform (Koh et al., 2004; Meyer et al., 2003).
The importance of PARG is demonstrated by lethality at the larval stage in
Drosophila parg -/- embryos suggesting that PARG is essential in the development of
the fruit fly (Hanai et al., 2004). parg-/- mouse embryonic stem cells survive but display
increased sensitivity to methylmethanesulfonate (MMS) and γ irradiation (Fujihara et al.,
2009). This supports the view that PARG is involved in the DNA repair response. PARG
is predicted to participate in DNA repair by removing PAR from modified proteins and
PARP-1 itself, leading to recondensation of chromatin (Rouleau et al., 2004). Also,
Maruta et al. suggested that PARG and ADP-ribose pyrophosphate can work together to
generate ATP from ADP-ribose (Maruta et al., 1997). As one might expect, this local
recycling of ADP-ribose to ATP would be beneficial during the ligation step in DNA
repair. These findings support the conclusion that PARG is involved in the DNA repair
response.

1.5.3. PARP-1 and Base Excision Repair
There is evidence that PARP-1 participates in BER. Using PARP-1-/- 3T3 cells
Dantzer et al. found that long-patch repair was severely affected by the lack of PARP-1
whereas short-patch repair was only slightly diminished (Dantzer et al., 2000). In
contrast, when studying the repair of plasmid DNA, Vodenicharov et al. found that
following irradiation or treatment with an alkylating agent PARP-1+/+ and PARP-1-/mouse embryonic fibroblasts had the same capacity to repair plasmid DNA. Additionally,
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repair occurred independently of NAD+ in a PARP-1 null background, but the presence
of PARP-1 restored the NAD+ dependency (Vodenicharov et al., 2000). The
discrepancies between these groups were partially resolved by Allinson et al. A cell-free
system demonstrated that PARP-1 actively slows down the progress of both BER subpathways even in the presence of NAD+ (Allinson et al., 2003). They propose that the
discrepancy could be due to differences in the experimental approach. Studies by Dantzer
et al. were based on nucleotide incorporation rather than monitoring of actual repair rates.
The results presented by Allinson et al. support a theory that the main role for PARP-1 in
BER does not lie in direct catalysis of DNA damage processing (Allinson et al., 2003).
This theory is supported by studies demonstrating the direct binding of PARP-1 to
essential proteins in BER, such as XRCC1 and DNA Ligase III (Caldecott et al., 1996;
Leppard et al., 2003; Masson et al., 1998; Nazarkina Zh et al., 2007). PAR is also
important in BER. Parsons et al. reported that PARP-1 binds to AP sites very early on in
the BER process. When PARP-1 activity is inhibited by 3-aminobenzamide, this blocks
PARP-1 dissociation and completely prevents further repair thus illustrating a role for
PAR in the progression of BER (Parsons et al., 2005). PAR formation has also been
implicated in recruiting BER proteins to damaged sites. Specifically, PARP activity is
required for the assembly and/or stability of XRCC1 nuclear foci after oxidative damage
(El-Khamisy et al., 2003). Lastly, DNA Ligase III has been shown to preferentially bind
poly(ribosyl)ated PARP-1, again demonstrating the importance of PARP-1 activity and
PAR in this DNA repair pathway (Leppard et al., 2003).
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1.5.4. PARP-1 and Nucleotide Excision Repair
The role of PARP-1 in NER is less researched. Currently, there are only a handful
of reports that discuss a role for PARP-1 in this DNA repair pathway. Flohr et al. used a
dominant negative approach to decrease PARP activity by transfecting a hamster cell line
with the PARP-1 DBD. Under conditions of PARP inhibition, they showed decreased
repair of pyrimidine dimers when compared to control cells. These data were confirmed
using the PARP inhibitor, 3,4-dihydro-5-[4-(1-piperidinyl)butoxyl]-1(2H)-isoquinolinone
(DPQ). There was no additive effect in the repair rates in csb-/- and DPQ treated cells
which suggested possible cooperation between PARP-1 and CSB protein as an
underlying mechanism (Flohr et al., 2003). A few years following this initial report,
Ghodgaonkar et al. more fully dissected PARP-1’s role in NER (Ghodgaonkar et al.,
2008). They utilized the host cell reactivation assay (HCR) which offers a simple model
where host cells are not irradiated but are required to repair exogenously damaged virus.
The cellular capacity for DNA repair is determined by the extent of expression of the
reporter gene. Using this approach, Ghodgaonkar et al. demonstrated decreased DNA
repair capacity of PARP-depleted NER-competent cells. Further studies to compare
repair capacity of XPC and CSB deficient cells revealed a significant decrease in HCR
capacity of PARP-depleted CSB cells at late time points (24h-44h) following UVB
exposure, again suggesting a cooperative role between PARP-1 and CSB (Ghodgaonkar
et al., 2008). Overall, these studies suggest a role for PARP in NER but details relating to
its exact mechanism of action have yet to be fully elucidated.
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1.6.

Other PARP Family Members
As mentioned above, the PARP family consists of 18 members. It was noted that

Arabidopsis thaliana (a small flowering plant native to Europe) had gene coding for a
PARP-related protein that was structurally different than the PAR-related protein found
in maize (Ame et al., 1999). When PARP-1 -/- mouse embryonic fibroblasts (MEFs)
retained residual DNA-dependent PARP activity it was suggested that similar to plants,
mammals may also have other PARP family members. Ame et al. cloned this cDNA and
denoted the new protein as PARP-2 (65 kDa) and showed that it was a nuclear PARP
family member that catalyzed poly(ADP-ribose) in the presence of DNA damaging
agents. PARP-2 binds DNA, but in contrast to PARP-1 it does so through a nonconventional DNA binding domain (Ame et al., 1999). PARP-2 and several of the other
PARP family members retain homology to PARP-1 in their C-terminal region, referred to
as the catalytic site. This site is a 40 kDa fragment that is sufficient for PARP-1’s
catalytic activity (Ruf et al., 1996; Simonin et al., 1993). PARP-2 has 60% homology to
PARP-1 within this region (Smith, 2001). Schreiber et al. further characterized PARP-2
and found its expression pattern within tissues similar to that of PARP-1. PARP-2
interacted with BER proteins XRCC1, DNA pol β, and DNA Ligase III, all of which also
bind PARP-1. PARP-2 was also found to be a functional component of BER, likely
through its interaction with PARP-1.(Schreiber et al., 2002). PARP-2, and more recently
PARP-3, are the only other PARP family members involved in the DNA damage
response. PARP-2 contributes about 5-10% of the total PARP response following DNA
damage and PARP-3 contributions are under investigation (Boehler et al., 2011; Yelamos
et al., 2008). Several reports have begun to address more specific functions for PARP-2
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in areas other than the DNA damage response. Some of these include a possible role for
PARP-2 in differentiation, the inflammatory response and its use as a target for therapy
[review (Yelamos et al., 2008)]. Despite the number of PARP family members only three
appear to actively participate in DNA repair and PARP-1 is the major protein.
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Rationale
It is imperative to investigate the underlying mechanisms of DNA repair
pathways because unrepaired or misrepaired DNA lesions may lead to mutations and
promote cancer. In addition, therapeutic modulation of DNA repair is an emerging
strategy for cancer therapy. While there is some evidence to support a possible
contribution of PARP to NER, our goal is to further define a mechanism of action for
PARP in this repair pathway.
The work described in this dissertation tested the following hypothesis:

Hypothesis
Following UVR exposure PARP-1 activation and subsequent formation of PAR
subunits allow PARP-1 to interact with essential proteins in NER, thereby contributing to
the repair of ultraviolet induced photoproducts (Fig. 1.5).

FIGURE 1.5. Model of PARP-1’s role in NER. A, In the resting cell, basal levels of PARP-1 activity are
low. B, Following UVR exposure, PARP-1 becomes activated and forms poly(ADP-ribose) subunits[PAR]
which are placed on PARP-1 itself and other acceptor proteins. C, PAR act as a scaffold for NER
components which contribute to the repair of UV-induced photoproducts.
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The specific aims to test this hypothesis are as follows:

Project Aims

Aim 1: Establish a role for PARP-1 in the repair of ultraviolet induced DNA
damage in keratinocytes
Hypothesis: Loss of PARP-1 expression (shRNA) or activity (pharmacologic inhibitors)
will lead to increased retention of UV-induced photolesions repaired by NER
Results: Chapter 2 (cellular systems) and Chapter 4 (in vivo)

Aim 2: Identify whether the mechanism of PARP-1’s involvement requires its
catalytic activity thereby promoting PARP-1 interaction with NER proteins
Hypothesis: Following UVR exposure, activation of PARP-1 will lead to the formation of
PAR subunits which act as a scaffold for components of the NER pathway
Results: Chapter 2 (XPA) and Chapter 3 (XPC)

Aim 3: Establish the impact of decreased PARP-1 activity on NER proteins
Hypothesis: Modifications to PARP-1 catalytic activity, by pharmaceutical approaches,
will reduce PAR formation thereby disrupting the scaffold needed for PARP-1 interaction
with NER proteins
Results: Chapter 2 (XPA) and Chapter 3 (XPC)
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CHAPTER 2
Data contained within this chapter has been accepted for publication in the Journal of
Biological Chemistry (King et al., 2012).
Authors include: Brenee S. King, Karen L. Cooper, Ke Jian Liu and Laurie G. Hudson
2.
Poly(ADP-ribose) contributes to an association between Poly(ADPribose)polymerase-1 and Xeroderma pigmentosum complementation group A in
nucleotide excision repair
2.1.

Introduction
Keratinocytic tumors (basal cell and squamous cell carcinomas) are the most

common cancers in the United States and solar ultraviolet radiation (UVR) is the major
etiologic factor (Narayanan et al., 2010). Solar UVR exposure forms DNA photoproducts
such as cyclobutane pyriminde dimers (CPDs) and (6-4) pyrimidine-pyrimidone
photoproducts (6-4 PPs) which are helix distorting lesions repaired predominantly by
nucleotide excision repair (NER) (Nouspikel, 2009; Park and Choi, 2006). If such lesions
are retained, they may lead to mutations, chromosome aberrations and cellular
malfunctions including cell death, senescence and cancer (Pfeifer et al., 2005; Sinha and
Hader, 2002).
Poly(ADP-ribose)polymerase-1(PARP-1) has numerous functions in cells
including orchestration of DNA damage response (Woodhouse and Dianov, 2008). While
PARP-1’s involvement in single strand break repair and base excision repair (BER) is
established, less is known regarding the contributions of PARP-1 to NER. Chemical
inhibition of PARP activity or over expression of the PARP-1 DNA binding domain
decreased CPD repair rate in a transformed cell line (Flohr et al., 2003) and PARP
depletion by RNA interference (RNAi) decreased host cell reactivation of a UVR26

damaged reporter gene in fibroblasts (Ghodgaonkar et al., 2008). While these studies
provide evidence that PARP enzymes may modulate NER, little insight exists into a
mechanism to account for these observations.
PARP-1 is rapidly activated in response to DNA damage leading to consumption
of NAD+ as a substrate to form poly(ADP-ribose) subunits [PAR] and accounts for more
than 70% of PAR production by PARP enzymes (Burkle, 2001; Schreiber et al., 2002).
PAR residues bind to acceptor proteins including PARP-1, histones and various proteins
involved in DNA processing and repair. PAR fosters protein:protein associations (Hassa
and Hottiger, 2008; Malanga and Althaus, 2005; Schreiber et al., 2006) and a PARbinding motif has been identified in certain proteins, including xeroderma pigmentosum
complementation group A protein (XPA) (Pleschke et al., 2000). XPA is part of a group
of core proteins that are essential for the initial phase of the NER process (Aboussekhra
et al., 1995; Mu et al., 1995). Data suggests that loss of this protein, through silencing or
chemical suppression, can decrease repair of UVR-induced photoproducts and lead to
increased cell sensitivity to DNA damaging agents, therefore, illustrating that loss of the
XPA protein is rate-limiting to NER (Kang et al., 2011b; Koberle et al., 2006).
Additionally, XPA binding, in conjunction with RPA, is proposed to be important in a
secondary recognition step that verifies the presence of DNA lesions. Along these lines,
XPA may also provide a checkpoint to control three-dimensional organization of NER
complexes (Bartels and Lambert, 2007; Missura et al., 2001). These data support the
critical role for the XPA protein as well as its function in NER. Biochemical studies
established the location of a PAR-binding motif in XPA and confirmed that the motif
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conferred PAR binding (Fahrer et al., 2007; Pleschke et al., 2000), but the functional
significance of this motif has not been defined.
In this study, we demonstrate that inhibition of PARP activity, or PARP-1
knockdown, causes retention of UVR-induced photoproducts in human keratinocytes.
UVR exposure stimulated PARP activity and promoted association between XPA and
PAR as well as XPA and PARP-1. Inhibition of PARP activity: 1) decreased the
association between XPA and PARP-1 in whole cell extracts, 2) decreased the
association between XPA and chromatin-bound PARP-1 and 3) blocked UVR-induced
XPA association with chromatin, suggesting that these associations and XPA recruitment
to chromatin is dependent on poly(ADP-ribosyl)ation. These results not only confirm a
role for PARP-1 in NER, but suggest a mechanistic link for PARP activity in the repair of
UVR-induced photoproducts.

2.2.

Materials and Methods
Cell lines. The human keratinocyte cell line (HaCaT) was generously provided by

Dr. Mitch Denning (Loyola University Medical Center, Maywood, IL). HaCaT cells were
maintained as described previously (Ding et al., 2009). PARP-1 HuSH cells were created
by transfecting HaCaT cells with a PARP-1 shRNA (Origene, HuSH 29mer). Stable
clones were selected using 0.5 μg/ml puromycin and maintained in growth media
supplemented with 0.3 μg/ml puromycin. Decreased PARP-1 protein and mRNA was
confirmed by western blot and northern blot analysis, respectively. Human embryonic
kidney (HEK) 293 cells were cultured in Dulbecco's Modified Eagle's Medium (DMEM)
supplemented with 10% fetal bovine serum (FBS), 2 mM L-glutamine and antibiotics
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(penicillin, 100 U/ml and streptomycin, 100 μg/ml). Cells were cultured at 37 °C in 95%
air/5% CO2 humidified incubator.
Antibodies. Antibodies used include: Anti-PAR (Alexis Biochemical/Enzo Life
Science), Anti-Thymine dimer clone KTM53 (CPD) and Anti-(6-4) photoproducts clone
KTM50 (Kamiya Biomedical Company), Anti-XPA (Abcam, ab2352), Anti-XPA
(Abcam, ab85914 for immunoprecipitation), Anti-PARP (Cell Signaling, #9542), AntiPARP (Cell Signaling, #9532 for immunocytochemistry), Anti-GAPDH (Millipore),
Anti-β tubulin (Santa Cruz), anti-rabbit and anti-mouse IgG, HRP conjugated (Promega),
goat anti-rabbit IgG FITC conjugated and donkey anti-mouse IgG, Cy3 conjugated
(Millipore).
UVR exposure and DPQ treatments. Cells at 50-60% confluent density were
placed in phosphate buffered saline (PBS) and exposed to 3 kJ/m2 solar-simulated
ultraviolet radiation (ssUVR) using an Oriel 300W Watt Solar Ultraviolet Simulator
(Newport Corporation, CA). The number of MED (minimal erythema dose) for 3 kJ/m2 is
0.042 as measured by the Erythema UV and UVA Intensity Meter (Model 3D, Solar
Light Company, PA). This dose resulted in 88% viability at 24hrs. After UVR exposure,
PBS was replaced with growth media for times indicated in figures. Levels of UVRinduced photoproducts at zero time were performed, and there was no difference in initial
photoproduct formation between HaCaT and PARP-1 HuSH cells. For the indicated
studies, cells were exposed to 10μM 3,4-dihydro-5-[4-(1-piperidinyl)butoxyl]-1(2H)isoquinolinone (DPQ, Santa Cruz Biotechnology) for 30 minute before UVR exposure.
DPQ was present in the post-exposure incubation medium. Cells that were not treated are
labeled as NT.
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Western blotting. For total cell lysates, cells were collected in PARP lysis buffer
(20mM Tris base (pH 7.5), 1mM EDTA, 1mM EGTA, 1% triton X-100, 25mM sodium
pyrophosphate, 1mM β-glcycerol phosphate, 1mM sodium vanadate, 1μg/ml leupeptin
and 2mM PMSF) and extracts clarified by centrifugation (8,000 rpm at 4oC for five
minutes). Cytoplasmic and nuclear cell fractions were obtained as described for the
CellLytic NuCLEAR Extraction Kit (Sigma). Protein concentrations were measured
using the BCA Protein Assay (Thermo Scientific). 30 μg protein in loading buffer (3x,
187.5mM Tris-HCl, pH 6.8, 6% w/v SDS, 30% glycerol, 150mM DTT and 0.03% (w/v)
bromophenol blue) was heated at 100oC for 5 minutes, resolved on a 10% sodium
dodecyl sulfate (SDS)-polyacrylimide gel and transferred to nitrocellulose or
polyvinylidene fluoride (PVDF) membranes. Proteins were detected as previously
described (Qin et al., 2008b). Band signal intensity was obtained using a Kodak 440CF
Imager Digital Science Image Station. To control sample loading and protein transfer,
membranes were stripped and re-probed to detect GAPDH. GAPDH was tested and
found not to change following treatment conditions.
NAD Assay. Experiments were conducted according to the manufacturer’s (Cell
Technology Inc., CA) protocol for the Fluorescent NAD+/NADH Detection Kit.
Detection of UVR-induced photoproducts. 6-4 PPs or CPDs were detected as
described in (Ding et al., 2009) [protocol for 8-OHdG] with the following
modifications: Fixed cells were not treated with RNase or proteinase K. Cells were
incubated in 10% normal horse serum in PBS overnight. Anti 6-4 PP or CPD antibody
was incubated with cells at a 1:1000 or 1:200 dilution, respectively, for 1 hour at 37oC in
a humid chamber. Cells were washed with PBS then incubated with secondary antibody
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(1:300) for 1 hour at 37oC in a humid chamber. Following incubation with secondary
antibody, cells were washed with PBS and mounted with Vectashield mounting media
containing 2 μg/mL DAPI (Vector labs). Images were obtained using a Zeiss Axioscope
40 using a 40x objective with an Optronics MacroFire camera and PictureFrame 2.1
picture software. Images used for comparison were acquired with the same instrument
settings and exposure times. Three to five images per cell type and time point were
obtained and intensity measurements were quantified using Image J (NIH).
In addition, levels of genomic photoproducts were measured using a slot blot
(Minifold II, Whatman International) immunoassay using antibodies to 6-4 PP (1:1000)
and CPDs (1:2000). Sample preparation and slot blot procedure were conducted
according to the Bio-Dot SF Instruction Manual (BioRad). Nitrocellulose membranes
were placed in blocking solution for 1 hour (5% dried milk made in tris buffer saline with
0.05% Tween-20 [TBST]), primary antibodies were incubated for 1 hour followed by
incubation with secondary antibodies for 1 hour. Membranes were washed for 20 minutes
and signal intensity was obtained using a Kodak 440CF Imager Digital Science Image
Station. After imaging, membranes were stained with methylene blue for 5 minutes in
order to obtain total DNA in each well. Intensity measurements were normalized to total
DNA in each well.
Immunoprecipitation. PAR, PARP-1 or XPA were immunoprecipitated from 7501000 μg of protein in PARP lysis buffer as described in (Zhou et al., 2011) with the
following modifications. Primary antibodies (1:100 dilution) were incubated with protein
for 1 hour at 4oC followed by addition of protein A agarose beads (Invitrogen) and
further incubation for 1 hour at 4oC. Beads were isolated by centrifugation (4,500 rpm at
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4oC for five minutes) and washed three times with PARP lysis buffer. To elute protein,
loading buffer (see western blotting) was added to pelleted beads and heated at 100oC for
5 minutes and resolved by SDS- polyacrylimide gel as described above in the western
blotting section.
Immunocytochemistry (ICC). In situ detection of XPA and PARP-1 was
conducted as described in (Schwerdtle et al., 2010) with the following modifications.
XPA (1:50) and PARP-1 (1:150) antibodies were diluted in washing buffer (0.5% bovine
albumin, 0.05% Tween-20). Secondary antibodies were used at 1:300 (FITC) and 1:500
(cy3) dilutions. Primary and secondary antibodies were added simultaneously during the
appropriate steps. Five images per group were obtained using an LSM 510-META
confocal with a 63x objective. For colocalization analysis, cy3 (XPA) and FITC (PARP1) intensity measurements were obtained with individual masks for the respective
channels and colocalization was determined in Slidebook 5.0 (Intelligent Imaging
Innovations Inc., CO) using percent colocalization or Pearson’s correlation coefficient.
Chip-on-western. Chromatin preparation was adapted from (Fousteri et al., 2006)
and collection protocol was followed as stated. Following collection, chromatin
suspension was sonicated on ice (1 x 90sec) in RIPA buffer (0.01 M Tris-HCl ph 8.0,
0.14M NaCl, 1% Triton X-100, 0.1% deoxycholate, 1% SDS) using a Branson Sonifer
(Output 5, Duty 40%, pulsed). Samples were isolated by centrifugation (13,200 rpm at
4oC for 15 minutes) with the supernatant containing cross-linked chromatin. A 50 μl
aliquot of the supernatant was used to determine DNA concentration using the DNeasy
Blood and Tissue Kit (Qiagen). For each sample, an equal amount of cross-linked
chromatin (40-50 μg) was immunoprecipitated with 1:100 dilution of specific antibody
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(XPA 12F5 or PARP-1 #9542). For immunoprecipitation of PARP-1, samples were
incubated in primary for 1 hr at 4oC. The immunocomplexes were absorbed onto precleared sepharose Protein A beads (GE Healthcare) for 1 hr at 4oC. Samples were washed
three times in PARP lysis buffer and lastly in LiCl buffer (0.02 M Tris [pH 8.0], 0.25 M
LiCl, 0.5% Triton X-100, 0.5% Na-deoxycholate), resuspended in loading buffer (see
Western blotting), and boiled for 30 minutes at 100oC before being loading onto a 10%
polyacrylaminde gel. The western blotting protocol (above) was followed. The protocol
for immunoprecipitation of XPA was adjusted as follows; samples were incubated in
primary for 3 hrs at 4oC. The immunocomplexes were absorbed onto pre-cleared Protein
A and Protein G beads (1:1 ratio, Invitrogen) for 3 hrs at 4oC. Beads were washed as
stated in (Fousteri et al., 2006), resuspended in loading buffer (see Western blotting), and
boiled for 30 minutes at 100oC before being loading onto a 10% polyacrylaminde gel.
The western blotting protocol (above) was followed. For analysis, band signal intensity
was obtained using a Kodak 440CF Imager Digital Science Image Station. All negative
control samples were incubated with normal rabbit IgG-AC (Santa Cruz) and processed
similar to samples incubated with primary antibody. We confirmed the presence of
photolesions in the same soluble chromatin fraction used to perform
immunoprecipitations by blotting the fraction onto a membrane using a slot blot
apparatus (see above protocol, Detection of UV-induced photoproducts, slot blot).
Statistical Analysis. All graphs and statistical data were completed using
GraphPad Prism 5 (GraphPad Software Inc., CA). Analysis used: unpaired t-test, Twoway ANOVA analysis with Bonferroni’s correction, One-way ANOVA followed by
Tukey’s post-hoc multiple comparison test.
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2.3.

Results
UVR-induced photoproducts are retained following reduction of PARP activity

through protein silencing or chemical inhibition - To investigate the impact of PARP-1
depletion on retention of UVR-induced photoproducts in cancer-relevant target cells,
immortalized human keratinocytes (HaCaT) were transfected with a short hairpin RNA
directed toward the PARP-1 protein (PARP-1 HuSH). A 60% reduction in PARP-1
protein levels was detected by western blotting (Fig 2.1A and 2.1B) which corresponded
to a 60% reduction in basal PAR levels (Fig. 2.1C, NT) and a 70% reduction in PARP
activation following a single dose of 3kJ/m2 solar simulated UVR (Fig. 2.1C, 1h). The
accumulation of 6-4 PPs, as measured by fluorescent intensity, in PARP-1 HuSH cells
remained elevated compared to HaCaT cells over a 6 hour time frame (Fig. 2.1D and
2.1E), suggesting decreased efficiency in repair mechanisms. Similar results were
obtained using the slot blot technique for UVR-induced 6-4 PPs (Fig. 2.1F) and CPDs
(Fig. 2.1G), further illustrating a role for PARP-1 in the repair of UV-induced lesions.
To expand on the above findings and examine the role of PARP activity, the
PARP inhibitor 3,4-dihydro-5-[4-(1-piperidinyl)butoxyl]-1(2H)-isoquinolinone (DPQ)
(Moroni et al., 2001; Suto et al., 1991) was used. This inhibitor significantly decreased
UVR-stimulated PARP activity as measured by PAR production (Fig. 2.2A) and resulted
in retention of 6-4 PPs (Fig. 2.2B) and CPDs (Fig. 2.2C). Taken together, these findings
demonstrate that reduction of PARP activity, either by PARP-1 silencing or chemical
inhibition, promotes retention of UVR-induced photolesions.
UVR promotes association between PARP-1 and XPA - PARP-1 activity was
stimulated by UVR, as measured by decreased cellular NAD+ (Fig. 2.3A)
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FIGURE 2.1. Effects of PARP activity on retention of UVR-induced photoproducts. A, Representative
western blot comparing PARP-1 protein in HaCaT and PARP-1 HuSH cells. GAPDH is used as a loading
control. B, Quantification of (A) by densitometry. PARP-1 intensity was normalized to GAPDH. Data
presented as means ± SEM, n=3. C, Quantification of PAR western blots by densitometry in HaCaT and
PARP-1 HuSH cells following UVR exposure. Data presented as means ± SEM, n=3. D, HaCaT cells and
PARP-1 HuSH cells were exposed to a single dose of ssUVR (3 kJ/m2) and collected at various times post
exposure. Immunofluorescence was used to obtain images of 6-4 PPs. Initial UVR-induced photoproducts did
not differ between HaCaT and PARP-1 HuSH cells. E, Fluorescence intensity obtained from images in (D).
HaCaT (open triangles) and PARP-1 HuSH (closed circles). Intensities were normalized to NT sample. Data
presented as means ± SEM, n=4. F,G Slot blot was performed on DNA extracted from HaCaT and PARP-1
HuSH cells. Quantification of lesion intensity by densitometry. Intensities normalized to NT. F, Intensity of 6-4
PPs formation. Data presented as means ± SEM, n=3. G, Intensity of CPD formation. Data presented as means
± SEM, n=3. *p<0.05, **p<0.01, ***p<0.001. Scale bar = 50μm.
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FIGURE 2.2. Inhibition of PARP activity results in retention of UVR-induced lesions. HaCaT cells
were pre-exposed to a PARP inhibitor, DPQ, 30 minutes prior to a single dose of ssUVR (3 kJ/m2) or
exposed to UVR alone and collected at various times post exposure. A, Quantification of PAR western blots
by densitometry. Data presented as means ± SEM, n=3. B, Quantification of 6-4 PPs obtained from
immunofluorescent images. UV only samples (open triangles) and DPQ+UV samples (closed circles).
Fluorescence intensity was normalized to NT sample. Data presented as means ± SEM, n=4. C,
Quantification of CPDs obtained from immunofluorescent images. Fluorescence intensity of raw data. Data
presented as means ± SEM, n=3. *p<0.05, **p<0.01, ***p<0.01.
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FIGURE 2.3. PARP activity is increased following UVR exposure. A, HaCaT cells were given a single dose
of ssUVR (3 kJ/m2) and allowed to incubate for various times post exposure. Following incubation, levels of
NAD+ were assessed using a fluorescent detection method. Data presented as means ± SEM, n=4. B, HaCaT
cells were given a single dose of ssUVR (3 kJ/m2) and collected at various times post exposure. Representative
western blot of PAR accumulation. GAPDH was used as loading control. C, Quantification of (B) by
densitometry. PAR intensity was normalized to GAPDH. Data presented as means ± SEM, n=4. *p<0.05,
***p<0.001.
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and a significant increase in PAR production (Fig. 2.3B and 2.3C). Given that
biochemical assays established that XPA contains a PAR binding motif (Pleschke et al.,
2000), we examined whether association between XPA and PAR could be detected
within an intact cellular system using co-immunoprecipitation of endogenous proteins.
Association between XPA and PAR was detectable in unstimulated cells (Fig. 2.4A, NT)
and this association was rapidly increased following UVR-exposure (Fig. 2.4A and Fig.
2.5A). Because PARP-1 is self-modified by PAR, we investigated the possible
association between XPA and PARP-1. Co-immunoprecipitation revealed UVR-induced
association between XPA and PARP-1 following immunoprecipitation of XPA
(Fig.2.4B) and PARP-1 (Fig. 2.5B). Immunofluorescence detection was performed to
evaluate co-localization of XPA and PARP-1 in situ. In agreement with the coimmunoprecipitation findings, a significant increase in XPA and PARP-1 co-localization
was detected one hour post UVR exposure (Fig. 2.4C and 2.4D). The co-localization was
transient with significant reduction apparent six hours following UVR (Fig. 2.4D). These
results demonstrate that the identified PAR binding motif in XPA is functional within
cells and suggest that it promotes UVR-induced associations of XPA with PAR and
PARP-1.
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FIGURE 2.4. UVR-induced associations between XPA and PARP-1. HaCaT cells were given a single dose of
ssUVR (3 kJ/m2) and collected at various times post exposure. A, Representative image of coimmunoprecipitation. XPA was immunoprecipitated (IP) from cells and membranes were subsequently
immunoblotted (IB) for PAR. Membranes were stripped and immunoblotted for XPA, as confirmation for
immunoprecipitation, n=3 B, Representative image of co-immunoprecipitation. XPA was immunoprecipitated
(IP) from cells and membranes were subsequently immunoblotted (IB) for PARP-1. Membranes were stripped
and immunoblotted for XPA, as confirmation for immunoprecipitation, n=3 C, Dual staining with antibodies
against XPA (red) and PARP-1 (green) was performed in order to assess the amount of colocalization (merge,
yellow). D, Quantification of intensities from (C). Percent colocalization was determined as stated in Methods.
Intensities were normalized to NT sample. Data presented as means ± SEM, n=3. ** p<0.01. Scale bar = 10μm.
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FIGURE 2.5. Interactions between XPA and PARP-1. HaCaT cells were given a single dose of ssUVR
(3 kJ/m2) and collected a various times post exposure. A, Representative image of co-immunoprecipitation.
PAR was immunoprecipitated (IP) from cells and membranes were subsequently immunoblotted (IB) for
XPA. Membranes were then stripped and immunoblotted for PAR, as confirmation for
immunoprecipitation. B, Representative image of co-immunoprecipitation. PARP-1 was
immunoprecipitated (IP) from cells and membranes were subsequently immunoblotted (IB) for XPA.
Membranes were then stripped and immunoblotted for PARP-1, as confirmation for immunoprecipitation.
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FIGURE 2.6. UVR-induced associations between XPA and chromatin bound PARP-1. HEK 293
cells were given a single dose of ssUVR (3 kJ/m2) and collected at various times post exposure. A
modified chromatin immunoprecipitation method (ChIP-on-western) was then performed. A,
Representative image of co-immunoprecipitation. PARP-1 was immunoprecipitated (IP) from cells
and membranes were subsequently immunoblotted (IB) for XPA. Membranes were stripped and
immunoblotted for PARP-1, as confirmation for immunoprecipitation. B, Quantification of western
blot by densitometry. Data presented as means ± SEM, n=5. * p<0.05
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In order to observe this association in a more direct context for PARP-1 function,
we isolated chromatin complexes using in vivo cross-linking followed by chromatin
immunoprecipitation, as described in (Fousteri et al., 2006). Chromatin fragments were
immunoprecipitated with a PARP-1 specific antibody. Following UVR exposure,
increased binding of PARP-1 with chromatin complexes was detected (Fig. 2.6A, IB:
PARP-1), which was expected based on PARP-1’s known function (Hassa and Hottiger,
2008). Furthermore, under conditions where PARP-1 had increased binding with
chromatin, it also associated with XPA. This association was significant 30 minutes
following UVR exposure (Fig. 2.6B). The extensive protocol used to isolate chromatin
complexes highlights that the observed association between PARP-1 and XPA is not
spurious. This relationship occurs under relevant conditions for NER proteins thus
demonstrating its potential to be meaningful in lesion repair.
Decreased PARP activity through silencing or chemical inhibition, results in
decreased association between PARP-1 and XPA – Next, we wanted to observe the
association between PARP-1 and XPA within PARP-1 HuSH cells. Results from Fig.2.1
show that decreasing PARP-1 protein and subsequently PARP activity results in retention
of UV-induced lesions. To better understand how PARP-1 associations with XPA may
contribute to these findings, we conducted immunoprecipitations with a PARP-1 specific
antibody in the PARP-1 HuSH cells. Immunoblotting for PARP-1 following its
immunoprecipitation from PARP-1 HuSH cells showed a significant decrease in PARP-1
protein (Fig. 2.7A, Table 1A) and PAR bound to PARP-1 itself (Fig. 2.7A, Table 1A).
This data corroborates results from Fig. 1A-C. More importantly, following
immunoprecipitation of PARP-1 from PARP-1 HuSH cells there was a significant
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decrease in its association with XPA when compared to HaCaT cells (Fig. 2.7A, Table
1A). Reciprocal immunoprecipitations also showed a decreased association between XPA
and PARP-1 in PARP-1 HuSH cells (Fig. 2.7B, Table 2.1B). Taken together, these data
suggest a contribution of the PARP-1 protein and/or its activity in its association with
XPA.

FIGURE 2.7. Silencing PARP-1 protein leads to decreased association between PARP-1 and XPA.
Co-immunoprecipitations were performed in HaCaT and PARP-1 HuSH cells. A, Representative image of
co-immunoprecipitations. PARP-1 was immunoprecipitated (IP) from cells and membranes were
subsequently immunoblotted (IB) for PARP-1, PAR and XPA. B, Representative image of reciprocal coimmunoprecipitations. XPA was immunoprecipitated (IP) from cells and membranes were subsequently
immunoblotted (IB) for PARP-1, PAR and XPA.
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TABLE 2.1. Quantification summary of immunoprecipitation data from HaCaT and PARP-1 HuSH
cells. Statistical analysis of data obtained from western blots shown in Figure 5. A, Quantification of
immunoprecipitations with PAPR-1 specific antibody. B, Quantification of immunoprecipitations with
XPA specific antibody, n=3.

FIGURE 2.8. Inhibition of PARP-1 activity also leads to decreased association between PARP-1 and XPA.
HaCaT cells were pre-exposed to a PARP inhibitor, DPQ, 30 minutes prior to UVR exposure. A, Cells were
collected 30 minutes post UVR. Representative western blot obtained from modified chromatin
immunoprecipitation method (ChIP-on-western). PARP-1 was immunoprecipitated from chromatin complexes.
Membranes were immunoblotted (IB) for XPA and subsequently immunoblotted for PARP-1 as confirmation for
immunoprecipitation. B, Quantification of western blot by densitometry. Data presented as means ± SEM, n=3.
C, HaCaT cells were pre-exposed to a PARP inhibitor, DPQ, 30 minutes prior to UVR exposure and cells were
fixed one hour post UVR. Dual staining with antibodies against XPA (red) and PARP-1 (green) was performed in
order to assess the amount of colocalization (merge, yellow). D, Graph representing colocalization between XPA
and PARP-1. Percent colocalization was determined using Pearson’s Correlation Coefficient. Data presented as
means ± SEM, n=3. * p<0.05, **p<0.01. Scale bar = 10μm.
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To investigate this further, we performed experiments using the pharmacological
PARP inhibitor, DPQ. Chromatin binding experiments confirmed a significant increase in
the association between chromatin-bound PARP-1 and XPA (Fig. 2.8A and 2.8B, UV)
which was abolished following DPQ exposure (Fig. 2.8A and 2.8B, DPQ+UV),
suggesting a role for PARP activation in the association between XPA and PARP. This
decrease in association was also observed when XPA was immunoprecipitated from
whole cell extracts and subsequently immunoblotted for PARP-1 (Fig. 2.9). Lastly,
immunofluorescent experiments provided similar results. Following UVR, there was
increased co-localization between PARP-1 and XPA (Fig. 2.8C, UV), again, following
DPQ exposure this association was significantly decreased (Fig. 2.8D, DPQ+UV).
Overall, these findings further demonstrate the importance of PARP activity in the
association between PARP-1 and XPA.
PARP inhibition leads to changes in XPA function – The main functions of XPA
are to bind DNA and interact with other NER proteins, thereby promoting DNA repair
(Camenisch and Nageli, 2008). To ascertain whether there were any changes to XPA’s
DNA binding ability as a function of PARP activity, cells were exposed to UVR with or
without DPQ treatment and collected five minutes post UVR. UVR exposure
significantly increased XPA binding to chromatin compared to unexposed cells (Fig.
2.10A and 2.10B, UV) and DPQ significantly decreased UVR-induced XPA association
with chromatin (Fig. 2.10B, DPQ+UV). These data demonstrate that PARP activity
regulates UVR-induced XPA association with chromatin, which begins to provide a
mechanistic link between PARP activity and NER.
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FIGURE 2.9. Inhibition of PAPR activity decreases the association between PARP-1 and
XPA. HaCaT cells were pre-exposed to a PARP inhibitor, DPQ, 30 minutes prior to a single
dose of UVR and collected five minutes post exposure. A, Representative image of coimmunoprecipitation. XPA was immunoprecipitated from cells (IP) and membranes were
subsequently immunoblotted (IB) for PARP-1. Membranes were stripped and immunoblotted
for XPA, as confirmation for immunoprecipitation. B, Quantification of western blot by
densitometry. PARP-1 intensity was normalized to NT. Data presented as means ± SEM, n=5.
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FIGURE 2.10. Inhibition of PARP activity effects XPA function. HEK 293 cells were pre-exposed to a
PARP inhibitor, DPQ, 30 minutes prior to UVR exposure and collected five minutes post exposure. A,
Representative western blot obtained from modified chromatin immunoprecipitation (ChIP-on-western). XPA
was immunoprecipitated (IP) from samples and its ability to bind chromatin was assessed by subsequent
immunoblotting (IB). B, Quantification by densitometry from ChIP-on-westerns. XPA intensity was
normalized to NT. Data presented as means ± SEM, n=4. *p<0.05, **p<0.01.
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2.4.

Discussion
Production of PAR by PARP enzymes modulates the association of DNA repair

proteins with sites of DNA damage and is important for the orchestration of DNA repair.
Although the involvement of PARP-1 in BER is well characterized, there is limited
knowledge regarding the contributions of PARP-1 to NER. Evidence to support a role for
PARP-1 in NER include retention of UVR-induced photoproducts previously described
(Flohr et al., 2003; Ghodgaonkar et al., 2008) and our data in keratinocytes (Fig. 2.1)
following disruption of PARP activity by expression of the PARP-1 DNA binding
domain, chemical inhibitors or RNAi. Current literature places a role for PARP-1 in the
transcriptional coupled repair arm of NER with studies supporting a cooperative interplay
between PARP-1 and Cockane syndrome B protein (CSB) (Flohr et al., 2003;
Ghodgaonkar et al., 2008). Our studies provide a novel alternative mechanism which
demonstrates an association between XPA and PARP-1 (Fig. 2.11). Because XPA is a
core NER protein and both transcription coupled repair and global excision repair
converge at an XPA-dependent step, these findings support the hypothesis that activated
PARP contributes to the retention of UVR-induced DNA photoproducts through
modulation of XPA.

FIGURE 2.11. Schematic of PARP-1
association with XPA. Following UVR
exposure PARP activity is increased
leading to the formation of PAR which
helps mediate the association between
PARP-1 and XPA.
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PARP-1 enzymatic activity is stimulated following DNA damage and the
consequent assembly of PAR subunits recruits DNA repair proteins to the lesion. There
are three main PAR- binding motifs responsible for mediating associations between PAR
and acceptor proteins. One PAR binding motif is a highly conserved domain known as
the ‘macro domain’ of approximately 130-190 amino acid residues. This motif is present
in several PARP family members such as PARP-9, PARP-14 and PARP-15 (Han et al.,
2010; Karras et al., 2005). Another PAR-binding motif is known as the PBZ domain.
This domain is a putative C2H2 zinc-finger and has been identified in the checkpoint
protein CHFR (checkpoint protein with forkhead-associated and RING domains) and the
DNA damage response protein APLF (aprataxin PNK-like factor) (Ahel et al., 2008; Li
et al., 2011). The best characterized PAR-binding motif contains approximately 20-25
amino acids with an N-terminal basic amino acid cluster followed by hydrophobic
residues interspersed with basic amino acids. This motif has been identified in several of
the core histones, p53, cyclin-dependent kinase inhibitor 1 (p21), XRCC1 and other
proteins including XPA (Malanga et al., 1998; Pleschke et al., 2000; Schmitz et al.,
1998). The presence of a PAR-binding motif in XPA was predicted by sequence
alignments that identified the 20-25 amino acid motif in the C-terminus of XPA. Polymer
blot experiments confirmed PAR binding properties of amino acids between 215-237
(Pleschke et al., 2000). Further in vitro analysis determined that polymers of ~16 PAR
units were necessary for XPA binding and high affinity XPA binding was evident using
immobilized long PAR chains (63-mer) (Fahrer et al., 2007). While these studies
suggested that PAR might influence XPA activity, the biochemical approaches did not
demonstrate in vivo significance.
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The current studies reveal that UVR promotes association of XPA with PAR
subunits (Fig.2.4 and 2.5). Additionally, PAR production by activated PARP enhances
UVR-dependent XPA association with bound PARP-1 (Fig. 2.8) and UVR stimulated
XPA association with chromatin (Fig. 2.10). These findings illustrate that XPA:PAR
associations occur in cells at endogenous protein levels and the association is relevant
based on the observed modulation of UVR-dependent XPA:DNA binding as a function of
PARP enzymatic activity in vivo. While the above data highlights a role for PARfacilitated interactions, there may be additional contributions due to PARP-1 itself.
PARP-1 silencing leading to decreased PARP-1 protein and enzyme activity (Fig. 2.1A-C
and Fig. 2.7) decreased the association between PARP-1 and XPA to a greater magnitude
than under conditions of pharmacologic PARP inhibition by DPQ. This suggests there
may be a dual mechanism during lesion repair that relies upon PARP activation and PAR
production which is augmented by direct protein interactions.
Additionally, we noted there was greater lesion retention in PARP-1 HuSH cells
when compared to inhibition of PARP activity alone (Fig. 2.1E compared to Fig. 2.1F,
10m post UV). A possible explanation could be due to PARP-1 itself being involved in
the recognition of UVR-induced photolesions in addition to it acting as a scaffold during
lesion repair. PARP-1 is able to directly bind platinum lesions which are also large, bulky
and helix-distorting (Zhu et al., 2010). While this report showed decreased binding of
PARP-1 to platinum lesions following its automodification, specific experiments with
CPDs and 6-4 PPs would need to be conducted in order to determine the individual roles
for the PARP-1 protein and its activity in lesion recognition.
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NER is regulated by multiple post-translational modifications including
PARylation, polyubiquitination and phosphorylation (Nouspikel, 2009). The breadth of
protein modification and regulation by PAR is currently unknown; however a mass
spectrometry based proteome-wide search for PAR-binding proteins and PAR-associated
complexes using the 20-25 amino acid PAR-binding sequence identified hundreds of
putative PAR-binding proteins (Gagne et al., 2008). Fewer proteins have been identified
with the alternate PAR binding motifs but database searches predicted 27 proteins
containing the PAR binding macro domain and four proteins with the PBZ domain
(Gagne et al., 2008). Although only a fraction of putative PAR acceptor proteins have
been analyzed, it is clear that in addition to PAR-dependent recruitment of BER proteins
such as XRCC1 and DNA Ligase III to sites of DNA damage, PARP activation
modulates multiple steps in the repair of DNA damage. PARylation of chromatinassociated proteins including histones and certain chromatin remodeling factors is
believed to modify local chromatin structure at sites of DNA strand breaks or damage
(Ahel et al., 2009; Gottschalk et al., 2009; Polo et al., 2010) and recently, Iduna was
identified as a PAR-dependent ubiquitin E3 ligase (Kang et al., 2011a). These findings
suggest that PARP activity and PAR production may influence numerous aspects of DNA
repair.
Overall, our findings further extend the impact of PARP activation in DNA repair
beyond the established role in BER by providing evidence for PAR-facilited modulation
of XPA as had been predicted by the identification of its PAR-binding motif. Due to the
centrality of XPA within NER, modulation of XPA by PAR provides a novel mechanism
to account for the observed relationship between loss of PARP function and retention of
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UVR-induced photolesions; thus, solidifying a role for PARP in NER. Further studies to
assess the functional significance of identified or predicted PAR binding sites in other
proteins will be necessary to delineate the scope of PARP activation in DNA repair and
other regulatory pathways.
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CHAPTER 3
The data within this paper is being submitted to the journal DNA Repair
Authors include: Brenee S. King, Ke Jian Liu, and Laurie G. Hudson

3.

Evidence for Poly(ADP-ribose)polymerase-1 Interactions With Xeroderma

Pigmentosum Complementation Group C (XPC)

3.1.

Introduction
Poly(ADP-ribose)polymerase-1 (PARP-1) is the most abundant PARP enzyme in

living cells. It has various functions in DNA damage repair, most notably base excision
repair (BER). This pathway is responsible for repairing small, non-helix distorting
lesions. For some time, it has been known that PARP-1 binds to DNA following damage.
DNA binding stimulates enzymatic activity leading to production of poly (ADP-ribose)
(PAR), and through its interactions with other BER proteins, such as XRCC1 and DNA
polymerase β, PARP-1 acts as a scaffold for recruitment of other proteins (Almeida and
Sobol, 2007; Caldecott et al., 1996; Dantzer et al., 2000). For example, experiments in
cells indicate that PARP activation and subsequent formation of PAR subunits
following oxidative damage facilitates XRCC1 assembly into nuclear foci (El-Khamisy et
al., 2003) and in vitro results demonstrate that XRCC1 preferentially binds to ribosylated
PARP-1 (Masson et al., 1998).
There is a more limited body of evidence to support a role for PARP-1 in
nucleotide excision repair (NER). The NER pathway is responsible for repairing bulky,
helix distorting lesions caused by exposure to ultraviolet radiation (UVR) and chemical
or cross-linking agents. Inhibition of PARP activity by over expression of its DNA
binding domain, gene silencing, or pharmacologic inhibitors leads to retention of
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ultraviolet-induced DNA lesions such as cyclobutane pyrimidine dimers (CPDs) and 6-4
pryrimidine pyrimidone dimers (6-4 PPs) (Flohr et al., 2003; Ghodgaonkar et al., 2008).
These studies suggest a role for PARP-1 in NER, but a mechanism to account for this
observation has yet to be fully elucidated.
An important early event in NER is DNA lesion recognition. In the global
genomic repair (GG-NER) arm of NER, xeroderma pigmentosum complementation
group C (XPC) protein is responsible for lesion recognition (Sugasawa, 2008, 2011). This
protein is part of a stable heterotrimeric complex which includes hHR23A or hHR23B (S.
cerevisiae RAD23p homologs) and centrin 2 (Kamionka and Feigon, 2004) and is
essential for initiation of GG-NER in in vitro and in intact cells (Sugasawa et al., 1998;
Volker et al., 2001). Specifically, XPC detects strongly helix-distorting lesions with high
affinity toward bubble structures and 6-4 PPs (Hey et al., 2002). One potential
mechanism to link PARP-1 to NER is through interaction with key NER proteins such as
XPC. A proteome-wide search conducted by Gagne et al. using the well-established
PAR-binding sequence based on the consensus motif hxbxhhbbhhb, initially identified
XPC as a potential PAR-binding protein (Gagne et al., 2008). Based on this information
we hypothesized that XPC associates with PARP-1 and that this interaction is mediated,
at least in part, through PAR.
In this study, we investigated potential interactions between XPC and PARP-1.
We find an association between XPC and PARP-1 within the cellular context and when
XPC is bound to chromatin. Importantly, PARP-1 did not interact with XPF, thereby
suggesting a level of selectivity for the association. The association between PARP-1 and
XPC is partially mediated by PAR and inhibition of PARP activity decreases UVR-
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induced XPC binding to chromatin. Taken together, these findings provide evidence that
the predicted PAR binding sequence on XPC (Gagne et al., 2008) is functional within
cells and that PARP activity leading to PAR production facilitates XPC binding to
damaged DNA.
3.2.

Materials and Methods
Cell lines. Human embryonic kidney (HEK) 293 cells were cultured in

Dulbecco's Modified Eagle's Medium (DMEM) supplemented with 10% fetal bovine
serum (FBS), 2 mM L-glutamine and antibiotics (penicillin, 100 U/ml and streptomycin,
100 μg/ml). Cells were cultured at 37°C in 95% air/5% CO2 humidified incubator. The
human keratinocyte cell line (HaCaT) was generously provided by Dr. Mitch Denning
(Loyola University Medical Center, Maywood, IL). HaCaT cells were maintained as
described previously (Ding et al., 2009). PARP-1 HuSH cells were created by
transfecting HaCaT cells with a PARP-1 shRNA (Origene, HuSH 29mer). Stable clones
were selected using 0.5 μg/ml puromycin and maintained in growth media supplemented
with 0.3 μg/ml puromycin. Decreased PARP-1 protein and mRNA were confirmed by
western blot and northern blot analysis, respectively.
Antibodies. Antibodies used include: Anti-XPC (Santa Cruz, A-5, for
immunoprecipitations), Anti-XPC (Abcam, ab20178, for western blotting), Anti-PAR
(Alexis Biochemical/Enzo Life Science), Anti-PARP-1 (Cell Signaling, #9542), AntiXPF (Abcam, ab7694) and anti-rabbit and anti-mouse IgG, HRP conjugated (Promega).
UVR exposure and AG-014699 treatments. Cells at 65-70% confluent density
were exposed to 3 kJ/m2 solar-simulated ultraviolet radiation (ssUVR) using an Oriel
300W Watt Solar Ultraviolet Simulator (Newport Corporation, CA). The number of
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MED (minimal erythema dose) for 3 kJ/m2 is 0.042 as measured by the Erythema UV
and UVA Intensity Meter (Model 3D, Solar Light Company, PA). This dose resulted in
88% viability at 24hrs (data not shown). After UVR exposure, cells were placed back in
the incubator for times indicated in figures. Cells were exposed to 50nM AG-014699
(Rucaparib, Selleck Chemicals) 1 hour before UVR exposure. AG-014699 was present in
the post-exposure incubation medium. Cells that were not treated are labeled as NT.
Immunoprecipitation. PARP-1 was immunoprecipitated from 750 μg of protein
as previously described in (Zhou et al., 2011), with the following modifications: PARP-1
primary antibody (1:100 dilution) was incubated with protein for 1 hour at 4oC followed
by addition of pre-cleared sepharose Protein A beads (GE Healthcare) for 1 hour at 4oC.
Beads were isolated by centrifugation (1,815 x g at 4oC for five minutes) and washed
three times with lysis buffer (20mM Tris base (pH 7.5), 1mM EDTA, 1mM EGTA, 1%
triton X-100, 25mM sodium pyrophosphate, 1mM β-glcycerol phosphate, 1mM sodium
vanadate, 1μg/ml leupeptin and 2mM PMSF). To elute protein, loading buffer (3x,
187.5mM Tris-HCl, pH 6.8, 6% w/v SDS, 30% glycerol, 150mM DTT and 0.03% (w/v)
bromophenol blue) was added to pelleted beads and heated at 100oC for 5 minutes.
Proteins were resolved on a 10% sodium dodecyl sulfate (SDS)-polyacrylimide gel.
Proteins then transferred onto nitrocellulose (Biorad) or polyvinylidene fluoride (PVDF)
membranes (Whatman). Proteins were detected as previously described (Qin et al.,
2008b). Band signal intensity was obtained using a Carestream 4000MM Pro Science
Image Station and Carestream MI software.
Chip-on-western. Chromatin preparation was adapted from (Fousteri et al., 2006)
and collection protocol was followed as stated: following collection, chromatin
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suspension was sonicated on ice (1 x 90sec) in RIPA buffer (0.01 M Tris-HCl ph 8.0,
0.14M NaCl, 1% Triton X-100, 0.1% deoxycholate, 1% SDS) using a Branson Sonifer
(Output 5, Duty 40%, pulsed). Samples were isolated by centrifugation (15,600 x g at 4oC
for 15 minutes) with the supernatant containing cross-linked chromatin. A 50 μl aliquot
of the supernatant was used to determine DNA concentration using the DNeasy Blood
and Tissue Kit (Qiagen). For each sample, an equal amount of cross-linked chromatin (50
μg) was diluted in lysis buffer (20mM Tris base (pH 7.5), 1mM EDTA, 1mM EGTA, 1%
triton X-100, 25mM sodium pyrophosphate, 1mM β-glcycerol phosphate, 1mM sodium
vanadate, 1μg/ml leupeptin and 2mM PMSF) and immunoprecipitated with specific
antibody. For immunoprecipitation of PARP-1, samples were incubated in primary
antibody at 1:100 dilution for 1 hr at 4oC. The immunocomplexes were absorbed onto
pre-cleared sepharose Protein A beads (GE Healthcare) for 1 hr at 4oC. Samples were
washed three times in lysis buffer and lastly in LiCl buffer (0.02 M Tris [pH 8.0], 0.25 M
LiCl, 0.5% Triton X-100, 0.5% Na-deoxycholate), resuspended in loading buffer (see
immunoprecipitation protocol), and boiled for 30 minutes at 100oC before being loading
onto a 10% polyacrylaminde gel. The protocol for immunoprecipitation of XPC was
adjusted as follows: samples were incubated in primary antibody at 1:100 dilution for 3
hrs at 4oC. The immunocomplexes were absorbed onto pre-cleared sepharose Protein A
beads (GE Healthcare) for 3 hrs at 4oC and washed three times with lysis buffer and lastly
in LiCl buffer. For protein elution, pelleted beads were resuspended in loading buffer,
and boiled for 30 minutes at 100oC before being loading onto a 10% polyacrylaminde
gel. For analysis, band signal intensity was obtained using a Carestream 4000MM Pro
Science Image Station and Carestream MI software. All negative control samples were
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incubated with normal rabbit or mouse IgG-AC (Santa Cruz) and processed similar to
samples incubated with primary antibody. We confirmed the presence of photolesions (64 PPs and CPDs) in the same soluble chromatin fraction used to perform
immunoprecipitations by blotting the fraction onto a membrane using the slot blot
technique (described in manufacturer’s protocol, Bio-Dot SF Instruction Manual,
BioRad). After imaging, membranes were stained with methylene blue for 5 minutes in
order to obtain values for total DNA in each sample.
Statistical Analysis. All graphs and statistical data were completed using
GraphPad Prism 5 (GraphPad Software Inc., CA). One-way ANOVA followed by
Dunnett’s Multiple Comparison Test (time course experiments) or Tukey’s post-hoc
multiple comparison test (AG-014699 experiments) were used for statistical analysis.
3.3.

Results
UVR promotes the association between PARP-1 and XPC. XPC is important for

the lesion recognition step of NER. A modified chromatin immunoprecipitation approach
was used to detect XPC binding to chromatin and potential association with PAR and
PARP-1. To detect DNA-binding proteins in a functional context, HEK 293 cells were
exposed to a single dose of UVR and collected at various times post exposure.
Endogenous proteins were cross-linked to DNA followed by immunoprecipitation with
an XPC-specific antibody. Under these conditions, we observed a significant increase in
XPC binding to chromatin at 5 minutes post-UVR (Fig 3.1A, IB: XPC and Fig. 3.1B).
These binding kinetics are in accordance with other findings using fluorescence recovery
after photobleaching (FRAP) (Hoogstraten et al., 2008), thus supporting the modified
chromatin immunoprecipitation approach.
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A putative PAR binding motif was identified in XPC (Gagne et al., 2008), but
PAR binding of XPC has not been tested. To determine whether XPC binds PAR, the
XPC chromatin complex was immunoprecipitated and immunoblotted using PARspecific antibodies. PAR was observed at each time point post UVR exposure (Fig. 3.1A,
IB: PAR). This time frame is sufficient to observe increases in total PAR following UVR
in mouse embryonic fibroblasts (Vodenicharov et al., 2005) and keratinocytes (data not
shown). This finding suggests XPC and PAR can associate in an intact cellular system
using endogenous proteins. The presence of PAR in the XPC chromatin
immunoprecipitation suggested that PARP-1 might be present given that PARP-1
enzymatic activity is responsible for the majority of PAR produced in response to DNA
damage (Burkle, 2001). Probing for PARP-1 revealed an increased association between
XPC and PARP-1 at five minutes post UVR exposure (Fig. 3.1A, IP: PARP-1). Potential
association between PARP-1 and XPC on chromatin has not been previously reported.
The finding was confirmed by conducting the reciprocal experiment using the modified
chromatin immunoprecipitation method. HEK 293 cells were exposed to a single dose of
UVR, collected at various times post exposure and a PARP-1 specific antibody was used
to isolate chromatin complexes. The association between PARP-1 and XPC was
significantly increased 5 minutes post UVR exposure (Fig. 3.1C and 3.1D). Taken
together, these results indicate that UVR stimulates XPC and PARP-1 binding to
chromatin and immunoprecipitated XPC is associated with PAR and PARP-1. Because of
evidence that PAR facilitates protein:protein interactions, it is possible that PAR
production by activated PARP-1 contributes to the XPC:PARP-1 interaction.
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FIGURE 3.1. UVR-induced associations between PARP-1 and XPC. HEK 293 cells were given a single dose
of ssUVR (3 kJ/m2) and collected at various times post exposure. A and C, A modified chromatin
immunoprecipitation method (ChIP-on-western) was performed. A, Representative image of coimmunoprecipitation. XPC was immunoprecipitated (IP) from cells and membranes were subsequently
immunoblotted (IB) for XPC, PAR and PARP-1. B, Quantification of XPC western blot from (A) by
densitometry. Data presented as means ± SEM, n=3 C, Representative image of co-immunoprecipitation. PARP1 was immunoprecipitated (IP) from cells and membranes were subsequently immunoblotted (IB) for XPC.
Membranes were stripped and immunoblotted for PARP-1, as confirmation of immunoprecipitation. D,
Quantification of XPC western blot from (C) by densitometry. Data presented as means ± SEM, n=5. All samples
were normalized to NT. * p<0.05.
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Reductions in PARP-1 activity decrease association between PARP-1 and XPC.
Previous findings showed PARP-1 silencing and enzyme inhibition led to retention of
UVR-induced DNA lesions in hamster cells and skin fibroblasts (Flohr et al., 2003;
Ghodgaonkar et al., 2008) so we used both approaches to investigate potential association
between PARP-1 and XPC in cell lysates. To test the impact of PARP-1 protein knockdown, we compared PARP-1 association with XPC in an immortalized human
keratinocyte cell line (HaCaT) to HaCat cells transfected with a PARP-1 shRNA (PARP1 HuSH cells). Following immunoprecipitation of PARP-1 from both cell types, the
PARP-1 protein and PAR production were decreased 75% and 80% respectively in HuSH
cells compared to parental control cells (Fig. 3.2A). A modest (22%), but significant
decrease in the association between PARP-1 and XPC was detected in the PARP-1 HuSH
cells when compared to the HaCaT cells (Fig. 3.2B).
To gain more insight into the role of PARP activity in the association between
XPC and PARP-1, we immunoprecipitated endogenous PARP-1 from cells treated with
the PARP inhibitor AG-014699 (Hunter et al., 2011; Kimbung et al., 2012; Plummer et
al., 2008). Following UVR exposure autoribosylation of PARP-1 was increased (Fig.
3.2C, IB: PAR, UV), and pre-incubation with the PARP inhibitor reduced PAR bound to
PARP-1 by 90% (Fig. 3.2C, IB: PAR, AG+UV). As observed using chromatin
immunoprecipitation (Fig. 3.1), UVR exposure led to an increased association between
PARP-1 and XPC as detected by co-immunoprecipitation from cell lysates (Fig. 3.2C,
IB: XPC, UV). However, this UVR–stimulated association was ablated when cells were
pretreated with the PARP inhibitor (Fig. 3.2C IB: XPC and 3.2D, AG+UV). These
findings suggest that PAR subunits contribute to the interaction
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FIGURE 3.2. Silencing of the PARP-1 protein or inhibition of its activity leads to a decreased
association between PARP-1 and XPC. A, Co-immunoprecipitations were performed in HaCaT and
PARP-1 HuSH cells. Representative image of co-immunoprecipitation. PARP-1 was immunoprecipitated
(IP) from cells and membranes were subsequently immunoblotted (IB) for PARP-1, XPC and PAR. B,
Quantification of XPC western blot from (A) by densitometry. Data presented as means ± SEM, n=4. C and
E, HaCaT cells were pre-exposed to the PARP inhibitor, AG-014699, 1 hour prior to UVR exposure and
collected five minutes post exposure. C, Representative image of co-immunoprecipitation. PARP-1 was
immunoprecipitated (IP) from cells and membranes were subsequently immunoblotted (IB) for PAR, XPC
and PARP-1. D, Quantification of XPC western blot from (C) by densitometry. Data presented as means ±
SEM, n=3. E, HaCaT cells were pre-exposed to the PARP inhibitor, AG-014699, 1 hour prior to UVR
exposure and collected thirty minutes post exposure. Representative image of co-immunoprecipitation.
PARP-1 was immunoprecipitated (IP) from cells and membranes were subsequently immunoblotted (IB) for
XPF, PARP-1 and PAR. F, Quantification of XPF western blot from (E) by densitometry. Data presented as
means ± SEM, n=4. All samples were normalized to NT. *p<0.05, ***p<0.001.
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between PARP-1 and XPC in response to UVR.
In order to assess selectivity of PARP-1 association, co-immunoprecipitation
studies were conducted for XPF, the last factor to enter the preincision complex during
NER (Fagbemi et al., 2011). In contrast to XPC, XPF does not have a putative PAR
binding sequence, thus is not predicted to interact with PARP-1 following UVR
activation. PARP-1 was immunoprecipitated from PARP-inhibitor treated and/or UVRexposed cells. Immunoblot for XPF showed no significant changes in the association
between PARP-1 and XPF under conditions where PARP-1 was activated (Fig. 3.2E, IB:
PAR, UV) or when PARP activity was inhibited (Fig. 3.2E, IB; PAR, AG+UV) Together,
the data surrounding XPC and XPF illustrate the importance of the PAR binding motif in
PAR associations with NER proteins.
Inhibition of PARP-1 activity results in decreased binding of XPC to chromatin.
The findings in Figure 3.2 demonstrate that PARP activity is essential for the UVRinduced co-immunoprecipitation of PARP-1 and XPC. Since XPC is essential in the
recognition of UVR-induced photoproducts (Rastogi et al., 2010; Rechkunova et al.,
2011; Sugasawa, 2008), the modified chromatin immunoprecipitation assay was used to
assess changes to XPC binding under conditions of PARP inhibition. UVR exposure
significantly increased XPC binding to chromatin (Fig. 3.3A and 3.3B, UV), similar to
what is shown in Fig. 3.1A (IB: XPC, 5m). Pretreatment of cells with the PARP inhibitor
AG-014699 significantly decreased UVR-induced XPC binding to chromatin (Fig. 3.3B,
AG+UV). Lastly, we investigated how the PARP-1:XPC chromatin complex changed
upon inhibition of PARP activity. Chromatin immunoprecipitation using PARP-1 as the
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FIGURE 3.3. Inhibition of PARP activity results in decreased binding of XPC to chromatin. A
and C, HEK 293 cells were pre-exposed to the PARP inhibitor, AG-014699, 1 hour prior to UVR
exposure and collected five minutes post exposure. A modified chromatin immunoprecipitation
method (ChIP-on-western) was performed. A, Representative image of co-immunoprecipitation.
XPC was immunoprecipitated (IP) from cells and membranes were subsequently immunoblotted
(IB) for XPC and PAR. B, Quantification of XPC western blot from (A) by densitometry. Data
presented as means ± SEM, n=6. C, Representative image of co-immunoprecipitation. PARP-1 was
immunoprecipitated (IP) from cells and membranes were subsequently immunoblotted (IB) for
XPC. Membranes were stripped and immunoblotted for PARP-1, as confirmation of
immunoprecipitation. D, Quantification of XPC western blot from (C) by densitometry. Data
presented as means ± SEM, n=3. All samples were normalized to NT. *p<0.05.
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probe demonstrated a significant increase in XPC following UVR exposure (Fig. 3.3C
and 3.3D, UV), and this increase in XPC was blocked when PARP activity was inhibited
(Fig. 3.3C and 3.3D, compare UV and AG+UV). Together, the data suggests PARP
activity not only potentially regulates XPC binding in response to DNA damage, but it
also participates in the formation of the PARP-1:XPC complex within chromatin.
3.4.

Discussion
The proteome-wide search for PAR-binding proteins performed by Gagne et al.

revealed a putative PAR binding motif in XPC (Gagne et al., 2008). The current studies
demonstrate that PAR was associated with endogenous XPC immunoprecipitated from
cells in a time dependent manner following UVR exposure (Fig. 3.1A). Furthermore,
chromatin-associated PARP-1 and XPC were co-immunoprecipited from UVR exposed
cells suggesting that both proteins are part of a complex (Fig. 3.4). Use of the PARP
inhibitor AG-014699, showed this complex was partially stabilized by PAR formation
(Fig. 3.2C and 3.3C).

FIGURE 3.4. Schematic of PARP-1
association with XPC. Following
UVR exposure PARP activity is
increased leading to the formation of
PAR which helps mediate the
association between PARP-1 and XPC.
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The importance of PAR in the BER repair pathway has been shown previously. DNA
Ligase III was shown to directly bind PAR and preferentially bind automodified PARP-1
(Leppard et al., 2003). Our data is novel because it reveals a possible mechanism for how
PARP and its activity may contribute to NER.
Recently, Luijsterburg et al. demonstrated that PARP inhibition suppressed UVRinduced immobilization of XPC-GFP and reduced its recruitment to damaged sites
(Luijsterburg et al., 2012). Our findings extend these observations by showing a
significant decrease in endogenous XPC binding to DNA complexes under conditions of
PARP inhibition (Fig. 3.3A). Together, these results suggest that activation of PARP-1 in
response to DNA damage and subsequent production of PAR may contribute to NER.
Further support for this idea is provided by our findings that PARP-1 and XPA interact
following UVR exposure (King et al., 2012). Importantly, XPA contains a PAR binding
sequence similar to the one predicated in XPC (Pleschke et al., 2000). In contrast,
following activation or inhibition of PARP activity, there were no significant changes in
the association between PARP-1 and XPF, another protein in the pre-incision complex
with no known PAR binding motif (Fig. 3.2F). These findings suggest that PAR binding
motifs are an important determinant linking PARP-1 activation and interaction with NER
proteins.
Other post-translational modifications of XPC have been identified including
sumolyation and ubiquitylation (Sugasawa, 2006; Wang et al., 2005). UV-induced
sumolyation is thought to protect XPC from degradation once it leaves the NER complex,
thereby allowing XPC to initiate a new round of damage recognition (Wang et al., 2005).
Additionally, polyubiquitulation of XPC augments its DNA binding activity (Sugasawa
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et al., 2005). These findings, in conjunction with the work of Luijsterburg et al. and the
data presented here, indicates the growing importance of understanding protein
modification as mechanisms underlying XPC and other NER protein function. Evidence
to support the presence of functional PAR-binding motifs in critical NER proteins
support a role for PARP activation in NER and more specifically, how PAR may be able
to regulate the function of central NER proteins such as XPC and thereby link PARP
activity to retention or repair of UV-induced photolesions.
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CHAPTER 4
4. In vivo inhibition of PARP activity by sodium arsenite results in retention of
UVR-induced cyclobutane pyrimidine dimers
4.1.

Introduction

4.1.1. Arsenic in the environment
Arsenic [As] is ubiquitous in the environment and is found in small quantities in
rocks, soil, water, air and food (EPA, 1984). It is a toxic element that is classified as a
human carcinogen. In the United States, India, Taiwan, Vietnam and Japan, the World
Health Organization’s set maximum contaminant levels for arsenic in drinking water is
10 μg/liter (Mohan and Pittman, 2007; WHO, 2004). Despite the current guidelines, it is
not uncommon to find levels of arsenic above this standard in drinking water. The US
Environmental Protection Agency (EPA) estimates that approximately 13 million people
in the US are exposed to arsenic at levels above 10 μg/liter (EPA, 2001). At least four
million people drink unhealthy arsenic levels in Mexico and several Latin American
countries (Argentina, Chile, El Salvador, Peru and Nicaragua). It is estimated that more
than 50 million people in Bangladesh drink water with levels of arsenic that exceed their
national standard of 50 μg/liter (Bundschuh et al.; Camacho et al., 2011; Mondal et al.,
2006). Overall, large populations are affected by arsenic exposure via ground water
consumption.
4.1.2. Arsenic carcinogenesis
Chronic health effects of arsenic exposure include peripheral heart disease,
ischemic heart disease, cerebral infraction, diabetes mellitus, hypertension and lastly skin
and internal cancers (Jomova et al., 2011; Yu et al., 2006). In a 1984 health assessment
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the EPA classified arsenic as a class I carcinogen based on epidemiologic data and the
quantitative risk with regard to its routes of exposure (ingestion and inhalation) (EPA,
1984). Specifically, bladder, lung, kidney, liver and uterus are often considered arsenicassociated malignancies (Chen et al., 2005; Ding et al., 2000; Jomova et al., 2011; Mead,
2005; Morales et al., 2000; Steinmaus et al., 2000). Currently there is sufficient evidence
in humans for arsenic and inorganic arsenic compounds as lung, skin and urinary bladder
carcinogens, and some evidence for these compounds as kidney, liver and prostate
(IARC, 2009). Whole life exposure models (in utero through weaning and adulthood)
demonstrate that arsenic is a complete carcinogen (Tokar et al., 2010; Tokar et al., 2011).
4.1.3. Genotoxicity
Arsenic does not cause point mutations in bacterial and standard mammalian cell
mutation assays (Barrett et al., 1989; Wang et al., 1996) but does cause large deletion
mutations in a human-hamster cell line (Hei et al., 1998). Micronuclei were found in
bone marrow of mice and in exfoliated bladder cells from exposed humans (Tinwell et
al., 1991; Warner et al., 1994). Additionally, at high concentrations arsenic induced
chromosome abberations (Lee et al., 1988; Mahata et al., 2003), and at lower
concentrations it induced sister chromatid exchanges (Huang et al., 1995; Kochhar et al.,
1996). The mechanisms of arsenic genotoxicity are not well understood, but arsenic can
cause DNA damage through the formation of chemically reactive molecules.
Arsenic generates reactive oxygen species (ROS) and reactive nitrogen species
(RNS) (Barchowsky et al., 1999; Cooper et al., 2007; Shi et al., 2004). Production of
reactive oxygen species following arsenic exposure can induce oxidative damage in
cellular DNA. One type of damage is the formation of DNA strand breaks. The
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development of single strand breaks can occur at low arsenite concentrations while
generation of double strand breaks is seen at concentrations of 5 μM in mammalian cells
(Martinez et al., 2011a; Schwerdtle et al., 2003b; Shi et al., 2004). Oxidative damage
also involves the formation of 8-OHdG adducts (Ding et al., 2005; Qin et al., 2008a;
Wanibuchi et al., 1997; Yamamoto et al., 1997). Clinical studies showed a positive
correlation between 8-OHdG staining and skin conditions such as arsenic-related skin
neoplasms and arsenic keratosis (Matsui et al., 1999). The combination of in vitro and in
vivo studies demonstrates the mutagenic potential associated with DNA damage caused
by arsenic-induced ROS.
4.1.4. Arsenic as a co-carcinogen
In addition to evidence that arsenic is a complete carcinogen, several studies
demonstrate that arsenic can work in combination with other DNA damaging agents. The
combination of ultraviolet radiation (UVR) and sodium arsenite resulted in a synergistic
increase in cytotoxicity, chromosome aberrations and mutations to 6-thioguanine and in
the hprt locus (Lee et al., 1985; Li and Rossman, 1991) in cells and a synergism between
arsenic and UVR in the development of skin tumors (Rossman et al., 2001). Evidence
suggests this is due to inhibition of DNA repair processes. Hartwig et al. exposed human
fibroblasts to low, non-toxic levels, of arsenite (2.5 μM) and demonstrated interference
with NER. The incision frequency was affected most severely and the ligation step was
inhibited but only at cytotoxic concentrations of sodium arsenite (20 and 50 μM)
(Hartwig et al., 1997; Rossman et al., 2004).
While the concept of arsenic as a co-carcinogen was discussed for some time,
details regarding specific molecular targets were lacking. Using the rationale that
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trivalent arsenic can inhibit the activity of thiol-containing enzymes, especially those
containing two sulfhydryl groups in close proximity (Fluharty and Sanadi, 1961;
Jennette, 1981), Li et al. investigated the role of arsenite inhibition on the activity of
DNA ligase III and found it to be diminished following arsenite exposure (Li and
Rossman, 1989).
Using the same rationale, Yager et al. investigated the inhibition of PARP-1
activity by arsenite treatment. They found a 50% decrease in PARP-1 enzymatic activity
following exposure to 10 μM arsenite (Yager and Wiencke, 1997). In contrast, studies by
Lynn et al. demonstrate a stimulatory effect of arsenite on PARP activity, it is pertinent to
mention they were using concentrations of 40 μM arsenite or above in their studies (Lynn
et al., 1998). A few years later, Hartwig et al. confirmed the inhibition of PARP activity
by arsenite exposure (Hartwig et al., 2003). These initial reports of arsenite inhibition of
DNA repair proteins provided the first data linking arsenite to a molecular targets and
impairment of DNA repair processes.
4.1.5. Arsenic inhibition of DNA Repair
Arsenic is a trivalent oxyanion that contains an unshared pair of 4 s electrons.
This characteristic allows it to bind proteins which could lead to conformational
alterations of protein structure or inhibit enzymatic activities of proteins. Arsenic has
been known to bind more than 200 proteins (Abernathy et al., 1999) many of which have
disulfide bonds (cysteine). Trivalent arsenicals bind with high affinity to proximal
sulfhydryl groups which are commonly found in DNA-binding proteins, transcription
factors and DNA-repair proteins (Kitchin, 2001; Kitchin and Wallace, 2005).
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A common structural feature of DNA-binding proteins is the zinc finger. These
small protein motifs contain finger-like protrusions that coordinate zinc which stabilizes
the secondary structure of a protein. Certain zinc finger-containing proteins such as DNA
ligase III, PARP-1 and XPA have been shown to be affected by arsenic exposure (Li and
Rossman, 1989; Schwerdtle et al., 2003a; Yager and Wiencke, 1997). Inhibition of
enzyme activity by arsenic exposure could lead to spontaneous or induced mutations in
key genetic sites leading to the possible development of cancer.
Data from our lab and our collaborators demonstrated arsenic interaction with the
zinc finger domains of PARP-1. Using mass spectrometry, Ding et al. showed covalent
binding of arsenite to an apopeptide of the PARP-1 zinc finger that could be reversed by
addition of zinc (Ding et al., 2009). In addition, zinc partially restored PARP activity and
diminished the exacerbating effects of arsenite on DNA damage (Qin et al., 2008a). The
interaction between arsenite and the PARP-1 zinc finger was further examined in studies
describing selectivity of arsenite for C3H1 and C4 zinc finger motifs (Zhou et al., 2011).
Several conclusions can be drawn from this series of studies: (1) arsenite is able to inhibit
PARP activity in cells, (2) inhibition of PARP activity in combination with other
damaging agents (H2O2 or UVR) can exacerbate DNA damage (8-OHdG or DNA strand
breaks), and (3) arsenite is able to inhibit PARP-1 through binding to its zinc-finger
domain. Overall, these data describe a molecular mechanism for arsenite inhibition of
DNA repair pathways. An animal study to test the potential interaction between arsenite
exposure and ultraviolet radiation was conducted to help confirm in vitro data
surrounding a role for PARP-1 in NER.
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4.2.

Materials and Methods
Animal handling and treatments. SKH-1 mice (21-25 days old) were purchased

from Charles River Laboratories (Wilmington, MA). Studies were performed under an
approved Institutional Animal Care and Use Committee (IACUC) protocol (#09-100408HSC). Animals were housed for seven days before start of treatments. All UVR
exposures were whole body with no restraints. For dose response studies: Animals were
exposed to varying doses of solar simulated ultraviolet radiation (ssUVR) [7 kJ/m2 to 35
kJ/m2] and all samples were collected one hour post exposure. For time course studies:
Animals were given a single dose (28 kJ/m2) of ssUVR. Following exposure, animals
were returned to their cages and samples collected at the appropriate time points post
exposure. For acute UVR exposure studies after arsenic treatment: Animals were housed
by treatment group and administered sodium arsenite (5 mg/l), zinc chloride (10 mg/l),
both or neither in the drinking water for 28 days. Water was changed every other day,
consumption monitored and volumes compared to untreated control animals to ensure
equivalent water consumption (data not shown). Controls and treated animals were
provided standard mouse chow ad lib. Animals randomly selected from each treatment
group were then exposed to a single dose (28 kJ/m2), 1.2 minimum erythema dose (MED)
of ssUVR, then euthanized 30 minutes post exposure. This time point was established in
preliminary studies and reflects a time point leading to significant, but not maximal,
levels of DNA damage (data not shown). For all studies: the irradiated and UVR naïve
dorsal skin was collected, preserved in 10% neutral buffered formalin and paraffin
blocks were prepared using standard procedures.
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Immunohistochemistry (IHC). Paraffin embedded tissue was sectioned using a
rotary microtome (Microm HM315) at a thickness of 10 m. For staining, slides were
deparaffinized with three exchanges of xylene (ten minutes each) followed by a one
minute exchange in absolute ethanol. Sections were rehydrated by sequential one minute
immersions in 95%, 75%, and 50% ethanol followed by five minutes in water. Slides
were then placed in a 1:10 dilution of H2O2 and methanol for twenty minutes. A DNA
unwinding step was performed using 0.125% trypsin for ten minutes at room
temperature, followed by three rinses with 1X phosphate-buffered saline (PBS). Slides
were then placed in 1N HCl for thirtry minutes at room temperature and subsequently
rinsed with 1X PBS. Slides were blocked in 5% BSA containing 10% goat serum for ten
minutes, then incubated with anti-CPD antibody (Thymine clone KTM53; Kamiya
Biomedical) at 1:250 dilution or poly(ADP) ribose [PAR] (Alexis Biochemicals) at 1:100
dilution overnight followed by anti-mouse secondary antibody conjugated to Cy3
(Chemicom) at 1:200 for one hour. Slides were mounted with VectaShield plus DAPI
(Vector Laboratories) and images were collected on a Zeiss LSM-510 META confocal
microscope using a 40x objective. A minimum of four images per section were taken and
the number of stained nuclei were counted and divided by the total number of nuclei in
each image to give the percentage of stained cells.
Western blotting. After sacrifice, dorsal skin was collected from irradiated and
UVR naïve mice. The collected skin sample was immediately placed flat, dermis side
down, on a metal block surrounded by dry ice in order to freeze the skin. The sample was
then scraped with the edge of a dissecting blade and the removed epidermis was place
into an eppendorf tube containing PARP lysis buffer (20mM Tris base (pH 7.5), 1mM
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EDTA, 1mM EGTA, 1% triton X-100, 25mM sodium pyrophosphate, 1mM β-glcycerol
phosphate, 1mM sodium vanadate, 1μg/ml leupeptin and 2mM PMSF) or RIPA buffer
(0.01 M Tris-HCl (pH 8.0), 0.14M NaCl, 1% Triton X-100, 0.1% deoxycholate, 1% sodium

dodecyl sulfate [SDS], 1mM sodium vanadate, 1μg/ml leupeptin and 2mM PMSF). Tubes
containing tissue samples were placed on dry ice and transferred to a -80oC freezer.
Before use, samples were allowed to defrost and were then sonicated on ice using a
Branson Sonifer (Output 5, Duty 40%) for two minutes and clarified by centrifugation at

20,000 x g. Samples were transferred to a new eppendorf tube, being careful not to
transfer non-dermal portions. Protein concentrations were obtained using the BCA
Protein Assay (Thermo Scientific). 10 μg of protein in loading buffer (3x, 187.5mM TrisHCl, pH 6.8, 6% w/v SDS, 30% glycerol, 150mM DTT and 0.03% (w/v) bromophenol
blue) was heated at 100oC for 5 minutes, resolved on a 10% SDS-polyacrylimide gel and
transferred to a nitrocellulose membrane. Anti-PAR antibody (Alexis Biochemcials) was
used at a 1:100 dilution. Band signal intensity was obtained using a Kodak 440CF Imager
Digital Science Image Station. To control sample loading and protein transfer,
membranes were stripped and re-probed to detect GAPDH (Millipore, 1:300 dilution).
Statistics. All graphs and statistical data were completed using GraphPad Prism 5
(GraphPad Software Inc., CA). Analysis used: Two-way ANOVA analysis followed by
Bonferroni’s correction.
4.3.

Results
DNA damage and PARP activation in mouse skin following exposure to ssUVR.

With the end goal of obtaining in vivo results on the actions of combined arsenite and
UVR exposure, the appropriate ssUVR dose and time frames for PARP activation and
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DNA damage needed to be obtained. Dose response experiments were performed with
SKH-1 hairless mice. Mice were exposed to varying doses of ssUVR and dorsal skin was
collected one hour post exposure. Subsequently, immunohistochemistry was performed
on skin removed from irradiated or UVR naive mice. PARP activation was detected using
specific antibodies against PAR. Colocalization was observed between PAR and DAPI
stained nuclei at doses of 7 kJ/m2 or greater (Fig. 4.1A, merge; white arrows).
Additionally, levels of direct DNA damage were investigated using specific antibodies
against CPDs. Increased lesion formation was clearly seen at doses of 28 kJ/m2 or higher
(Fig. 4.1B, merge, white arrows). From these results a dose of 28 kJ/m2 was selected for
time course experiments.
PARP activation and CPD formation are maximal at early times post UVR
exposure. Once a UVR dose was established, a time point for PARP activation and DNA
damage formation was determined. Mice were exposed to a single dose of ssUVR and
dorsal skin was collected at multiple time points (0-48 h) post UVR exposure. PARP
activation was determined by PAR staining. Colocalization between PAR and DAPI
stained nuclei was seen at early time points post exposure (30m and 1h) and appeared to
remain elevated four hours post exposure (Fig. 4.2, merge). These results regarding
PARP activation are similar to previously published results in cellular systems following
UVB exposure (Vodenicharov et al., 2005). CPD stained nuclei were observed one hour
post exposure and remained present at 24 hours post exposure. The majority of CPDs
were removed by 48 hours post UVR exposure (Fig. 4.3). These results are consistent
with data in the literature regarding CPD formation and repair in SKH-1 mouse skin
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FIGURE 4.1 PARP activation and
UVR-induced
DNA
damage
following varying concentrations
of ssUVR. SKH-1 mice were
exposed to varying concentrations
of
solar-simulated
ultraviolet
radiation (ssUVR) and subsequently
collected one hour post UVR
exposure. Dorsal skin was collected,
paraffin embedded and IHC was
performed. A, Staining for PAR to
evaluate
changes
in
PARP
activation following UVR exposure.
Cell nuclei are in blue (DAPI), PAR
(red) and areas where the two
overlap can be seen in purple
(Merge). B, Staining for CPDs to
assess the amount of UV-induced
DNA damage following UVR
exposure. Cell nuclei are in blue
(DAPI), CPD (red) and areas where
the two overlap can be seen in
purple (Merge). White areas
indicate areas of colocalization.

FIGURE 4.2 Time course of PARP activation following ssUVR exposure. SKH-1 mice were exposed to a single
dose of ssUVR (28 kJ/m2) and euthanized at the indicated times post UVR exposure. Dorsal skin was collected,
paraffin embedded and IHC was performed. Samples were stained for PAR to observe PARP activation following
UVR exposure. Cell nuclei are in blue (DAPI), PAR (red) and areas where the two overlap can be seen in purple
(Merge). White arrows indicate areas of colocalization.
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following UVR exposure (Lu et al., 1999). From these studies a dose of 28 kJ/m2 and a
time point at 30 minutes post UVR exposure were used for the acute arsenite studies.
Dual exposure to arsenite and ssUVR results in increased retention of UVRinduced DNA damage. Using the UVR dose and time point parameters obtained from
preliminary experiments, SKH-1 mice were exposed to 5 mg/l of sodium arsenite in their
drinking water for 28 days. On the last day of arsenite exposure, mice were exposed to a
single dose of ssUVR (28 kJ/m2) and dorsal skin was collected 30 minutes post UVR
exposure. Changes in UVR-induced DNA damaged were observed by using specific
antibodies for CPDs. As expected, animals exposed to UVR alone had an increased
number of CPD stained cells when compared to unexposed mice (Fig. 4.4A and 4.4B,
UV only). Animals given sodium arsenite in their drinking water followed by ssUVR had
an increased number of CPD stained cells compared to UVR exposure alone, suggesting
retention of CPDs upon arsenite exposure (Fig, 4.4A and 4.4B, As+UV). These results
complement cellular studies regarding delayed repair of CPDs following co-exposure of
arsenite and UVR (Ding et al., 2008).
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FIGURE 4.3 Time course of UVR-induced DNA damage following ssUVR exposure. SKH-1 mice were exposed
to a single dose of ssUVR (28 kJ/m2) and euthanized at various times post UV exposure. Dorsal skin was collected,
paraffin embedded and IHC was performed. Samples were stained for CPDs to observe UVR-induced DNA damage
following UVR exposure. Cell nuclei are in blue (DAPI), CPD (red) and areas where the two overlap can be seen in
purple (Merge). White arrows indicate areas of colocalization.
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FIGURE 4.4 Co-exposure of arsenite and UVR results in retention of UVRinduced DNA damage. SKH-1 mice were exposed to 5 mg/l of sodium arsenite
in their drinking water for 28 days. Mice where there exposure to a single dose of
ssUVR (28 kJ/m2). Dorsal skin was collected 30 minutes post UVR exposure,
paraffin embedded and the amount of UVR-induced DNA damage was observed
by performing IHC with antibodies against CPDs. A, Representative image of
CPD stained cells [red nuclei]) for each treatment group. B, Quantification of
CPD staining for each treatment group. The number of CPD stained cells was
divided by the total number of cells in the image (DAPI stain, not shown) to
obtain percentage of stained cells. n=5 animals. *p < 0.05
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Arsenite inhibits in vivo PARP activation. Arsenic interferes with the activity of
important DNA repair enzymes (Li and Rossman, 1989; Lynn et al., 1997). More
specifically, arsenite inhibits the activity of PARP-1 (Ding et al., 2009; Hartwig et al.,
2003; Qin et al., 2008a; Qin et al., 2008b; Yager and Wiencke, 1997). This inhibition
could provide a mechanistic link to explain the observed lesion retention under conditions
where mice were co-exposed to arsenite and ssUVR. Protein samples were collected from
dorsal skin of irradiated and UVR naïve mice. Proteins were separated on a
polyacrylaminde gel and subsequently probed for PAR as a marker for PARP activation.
Decreased PAR formation was observed in animals co-exposed to arsenite and UVR
when compared to animals exposed to UVR alone (Fig. 4.5). This suggests in vivo
inhibition of PARP activity following exposure to arsenite.
Zinc supplementation can counteract the effects of arsenite exposure. Coexposure of arsenite and zinc results in counteraction of the inhibitory effects of arsenite
on PARP activity and DNA repair in cells (Qin et al., 2008a; Qin et al., 2008b). To
investigate this observation in vivo, SKH-1 hairless mice were exposed to 10 mg/l zinc
chloride in their drinking water either alone or in combination with sodium arsenite. Mice
were subsequently given a single dose of ssUVR and direct DNA damage was measured
by quantification of CPD stained nuclei. Mice that were co-exposed to arsenite and zinc
in their drinking water had a comparable number of CPD stained nuclei then mice
exposed to UV alone (Fig. 4.6 As+Zn+UV compared to Fig.4.4 UV only). This was a
significant reduction compared to mice exposed to a combination of arsenite and UV,
which display an increased number of CPD stained cells when compared to UV alone
(Fig. 4.6 As+UV compared to As+Zn+UV).
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FIGURE 4.5 Exposure to arsenite is able to inhibit in vivo PARP activity. SKH-1 mice
were exposed to 5 mg/l of sodium arsenite in their drinking water for 28 days. Mice
where there exposure to a single dose of ssUVR (28 kJ/m2). Dorsal skin was collected 30
minutes post UVR exposure and epidermal protein was collected as described in
Materials and Methods. Proteins were separated on a polyacrylaminde gel and probed for
PAR in order to observe changes in PARP activity. GAPDH was used as a loading
control.
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FIGURE 4.6 Zinc supplementation is able to restore the deleterious effects of arsenic exposure.
SKH-1 mice were exposed to 5 mg/l of sodium arsenite, 10 mg/l of zinc chloride or a combination of
both in their drinking water for 28 days. Mice where then exposed to a single dose of ssUVR (28
kJ/m2). Dorsal skin was collected 30 minutes post UVR exposure, paraffin embedded and the amount
of UV-induced DNA damage was observed by performing IHC with antibodies against CPDs. A,
Representative image of CPD stained cells [red nuclei]) for the indicated treatment groups. B,
Quantification of CPD staining for all treatment groups. The number of CPD stained cells was divided
by the total number of cells in the image (DAPI stain, not shown) to obtain percentage of stained
cells. n=5 animals. **p < 0.01
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This data confirms cellular results regarding the ability of zinc to counter effects of
arsenite exposure in vivo.
4.4.

Discussion
Arsenic is defined as a class I human carcinogen (Martinez et al., 2011b) but its

mechanism of action remains under investigation. Many modes of action for arsenic
carcinogenesis have been identified, in particular its ability to act as a co-carcinogen
(Rossman et al., 2004; Yu et al., 2006). Arsenic inhibits proteins involved in BER and
single strand break repair (SSBR) but its effects in NER are under studied. Early reports
concluded that arsenite exposure creates partially repair-deficient conditions by impairing
the incision step in NER (Hartwig et al., 1997). Additionally, co-exposure of arsenite and
UVR resulted in increased mutagenicity in a human lymphoblast cell line (Danaee et al.,
2004). SKH-1 mice exposed to arsenic for 28 days and exposed to a single dose of
ssUVR retained more CPDs one hour post exposure then mice exposed to UVR alone
(Fig.4.4) suggesting arsenite exposure can effect CPD formation and/or repair in an in
vivo system. These results are similar to those obtained in vitro (Ding et al., 2008). Very
few studies have investigated arsenic’s ability to affect specific proteins in NER.
PARP-1 is a DNA repair protein known to be involved in BER and SSBR
(Woodhouse and Dianov, 2008). While the role of PARP-1 in NER is still under
investigation, several studies show decreases in PARP activity result in retention of
UVR-induced photoproducts such as 6-4 PPs and CPDs (Flohr et al., 2003; Ghodgaonkar
et al., 2008) and (Chapter 2, Figure 2.1). Arsenic inhibits PARP activity following
exposure to H2O2 and UVR exposure in vitro (Qin et al., 2008a; Qin et al., 2008b; Walter
et al., 2007). To our knowledge, there is no data showing inhibition of PARP activity by
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arsenite in vivo. Using protein obtained from dorsal skin of mice exposed to arsenite
alone, UVR alone, or a combination of both, we observed decreased PARP activity in
mice co-exposed to arsenite and UVR (Fig. 4.5). This data suggests that lesion retention
following co-exposure to arsenite and UVR may, in part, be due to inhibition of
important DNA repair proteins such as PARP-1. Additionally, I am currently
investigating the association of PARP-1 with NER proteins such as XPA and XPC.
Inhibition of PARP activity decreases the association between PARP-1 and XPA
(Chapter 2) and PARP-1 and XPC (Chapter 3). It is possible that in vitro experiments
translate in vivo and UVR-induced photoproduct retention is a result of arsenite inhibition
of PARP activity and decreased association with important NER proteins.
While data suggests inhibition of DNA repair through decreased PARP function,
there is also the possibility of direct inhibition of established NER proteins by arsenite
exposure. Nollan et al. showed decreases in XPC protein level as well as decreased
accumulation of XPC at damaged sites following 24 hour incubation with sodium
arsenite in human skin fibroblasts. They suggest the decreases in XPC protein is most
likely due to inhibition of XPC gene expression by arsenite (Nollen et al., 2009).
Additionally, several studies have investigated arsenic’s effects on XPA. Trivalent
arsenicals release zinc from a synthetic peptide based on the zinc finger region of XPA
(Beyersmann and Hartwig, 2008; Kitchin and Wallace, 2008). This data has recently
been complemented with studies showing arsenite selectivity for C4 zinc fingers, such as
the one found in XPA, leading to zinc loss and disruption in protein activity (Zhou et al.,
2011). These studies show that arsenic’s ability to affect UVR-induced photoproducts
involves several mechanisms. Lastly, the effects observed by arsenite exposure appear to
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be partially reversible. Co-exposure of arsenite and zinc results in decreased retention of
UVR-induced CPDs. In vitro and cellular studies show zinc is able to reduce the effects
of arsenite-induced oxidative or direct damage (Qin et al., 2008a; Qin et al., 2008b) and
(Cooper et al. unpublished).These results are most likely due to partially restored function
of the zinc finger domains found in PARP-1which are essential for DNA damage
recognition. Overall, this data suggests the results obtained in vitro and in cellular
systems occur in vivo.
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CHAPTER 5
5. Discussion and Future directions
PARP-1 is an enzyme with many functions throughout the cell. To date, its best
understood functions in DNA repair pathways have been centered on base excision repair
(BER). The data presented in this dissertation expands the knowledge on the role of
PARP in an additional arm in DNA repair, nucleotide excision repair (NER). Currently,
there is limited information regarding PARP’s mechanism of action in NER.
Ghodgaonkar et al. and Flohr et al. suggest a cooperative interaction between
PARP and CSB in repair mechanisms following UVR exposure (Flohr et al., 2003;
Ghodgaonkar et al., 2008). CSB is involved in the transcription coupled-repair (TC-NER)
arm of NER. Following stalling of RNA polymerase II, CSB is proposed to assist in the
assembly of repair factors (Fousteri and Mullenders, 2008; Rastogi et al., 2010). In
contrast, the XP family members are associated with global genomic repair (GG-NER)
and the steps common to both TC-NER and GG-NER. My findings provide strong
evidence that PARP is also involved in GG-NER through interactions with XPC and
XPA (Fig. 5.1).
Following UVR exposure, there is rapid activation of PARP-1 leading to the
formation of poly(ADP-ribose) [PAR]. Within this timeframe of PARP activation we
show PAR-enhanced association with NER proteins. Using co-immunoprecipitations of
endogenous proteins from cell lysates we observed UVR-enhanced associations between
PARP-1 and XPA as well as PARP-1 and XPC. A modified chromatin
immunoprecipitation method allowed us to monitor interactions of chromatin-associated
NER proteins. Within this environment, we again found UVR-enhanced associations
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between PARP-1 and XPA and PARP-1 and XPC. Due to the presence of a PAR-binding
motif within their sequences, both XPA and XPC have been identified as potential PARassociated proteins (Gagne et al., 2008; Pleschke et al., 2000).

FIGURE 5.1. Schematic illustrating potential role of PARP-1 in NER. Following
UVR exposure PARP activity is increased leading to the formation of PAR which
allows PARP-1 to associate with important NER proteins such as XPC and XPA.
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The importance of PAR in mediating interactions was demonstrated using PARP
inhibitors where decrease PAR production led to decreased associations between XPA
and XPC with PARP-1. Co-immunoprecipitations with PARP-1 and XPF, another XP
protein in NER with no known PAR-binding motif, did not show UVR-enhanced
association and PARP inhibition had no significant effect on the interaction between
these proteins. These results not only demonstrate the importance of PAR within NER
but also the PAR-binding sequence which can aid in selectivity for PARP-1 associations
with NER proteins.
XPC and XPA are crucial for two distinct roles in NER (Fig. 1.2). XPC enters the
damaged site early and is involved in lesion recognition. Once the DNA is unwound and
open, XPA enters the damaged area and assists in binding to various proteins within
NER. The ability of PAR to interact with two important NER proteins such as XPC and
XPA leads to further questions on the potential contributions of PARP to NER.
5.1.

XPC: Potential for PARP activity in lesion recognition
XPC is a central protein in lesion recognition within NER. While there is ample

information surrounding the types of lesions bound by XPC and the timing for XPC
lesion recognition (Hoogstraten et al., 2008; Rechkunova et al., 2011), the mechanism by
which XPC locates a lesion within the vastness of undamaged DNA is not clear (Rastogi
et al., 2010). PARP activation could assist at this stage in the repair process. Following
UVR exposure, PARP becomes active generating PAR as early as 15 seconds post
exposure and peaking around 5 minutes (Vodenicharov et al., 2005). This time frame
corresponds to XPC entry to the damaged area (Hoogstraten et al., 2008). It is possible
that PAR production following PARP activation could act in two ways. In one scenario,
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PARP-1 binding to damaged DNA and formation of PAR leads to recruitment of XPC to
the damaged site. Another possibility is that PARP and XPC enter the damaged area
simultaneously and PAR helps stabilize XPC binding to DNA during lesion recognition.
An experimental approach to further investigate this step would be to perform live cell
imaging using fluorescence recovery after photobleaching (FRAP). Recently,
Hoogstraten et al. used this method to gain insight into XPC mobility following cell
exposure to DNA damaging agents (Hoogstraten et al., 2008). Similar experiments that
monitor XPC mobility could be conducted using GFP-XPC under normal conditions and
under conditions where PARP activity was inhibited. The use of FRAP is advantageous
because it allows one to investigate actions of proteins seconds after insult. Monitoring
these very early events will be crucial to further understanding PAR/PARP-1
contributions to the entrance of proteins into a damaged area.
5.2.

XPA: Potential for PARP activity in complex stability
While XPA shows affinity for damaged DNA it is not recruited to DNA lesions

without prior recognition of the damage by XPC (Volker et al., 2001). Thus, a DNA
verification function has been proposed for XPA’s DNA binding ability (Camenisch et
al., 2006; Sugasawa et al., 1998). It is thought that following initial recognition by XPC,
binding of XPA helps to confirm the lesion is an NER substrate, thereby leading to a
higher degree of damage discrimination (Sugasawa et al., 1998). Our studies show that
inhibition of PARP activity leads to decreased binding of XPA to chromatin (Chapter 2).
Loss of XPA binding could decrease repair of UV-induced photoproducts and lead to
increased cell sensitivity to DNA damage. It is possible that PAR helps to stabilize XPA
binding. To further investigate the affects of PARP activity on XPA binding,
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electrophoretic mobility shift assays (EMSA) could be conducted with XPA specific
substrates under conditions of increased or decreased PARP activity. Additionally, an
EMSA to help determine if binding of PARP-1 protein has an effect on XPA binding
independent of its activity. It is also possible that PAR enhances the interaction between
XPA and other NER proteins, in this case acting as a scaffold with NER.
5.3.

PARP activity as a scaffold in NER
One important implication of this work is that PARP activation and PAR

production may play a more extensive role in assembly of DNA repair complexes than
previously understood. The data presented in this dissertation supports the hypothesis that
PARP-1 activation modulates NER, at least in part, through interactions between PARP-1
and important NER proteins through a PAR-binding motif. Currently there are three
known PAR binding motifs (Gagne et al., 2008); the most studied being the 25 amino
acid PAR-binding consensus sequence found within proteins such as XPA (Pleschke et
al., 2000). Gagne et al. conducted a proteome-wide search for PAR-associated proteins
using this 25 amino acid consensus sequence and found more than 300 potential PARassociated proteins (Gagne et al., 2008). XPC was on the list of potential candidates
along with DNA binding protein 1 (DDB1). While our data supports the functionality of
the predicted PAR-binding motif in XPC, overall, the data only provides a snapshot of
NER proteins that might interact with PARP-1. Additionally, our data suggests it is likely
that PARP activation will be important for assembly of multi-protein DNA repair
complexes.
As a first attempt to address this question, matrix-assisted laser
desorption/ionization mass spectrometry (MALDI-MS) followed by tandem mass
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spectrometry was employed to identify additional PARP-1 interacting NER proteins. The
experiment was to also serve as verification for PARP-1 interaction with both XPA and
XPC. The experimental design was to conduct ChIP-on-western experiments on control
or UVR-exposed HEK 293 cells using PARP-1 specific antibodies. Analysis of the
resulting immunoprecipitates identified a PARP-1 peak as expected; while proteins such
as mono-ADP-ribosyltransferase 3 (ART3) were detected, no NER proteins were
identified. It is possible that the strong intensity of the PARP-1 peak made it difficult to
identify low abundance proteins in the samples or that the MALDI-MS method is not
sufficiently sensitive for our purposes. Future studies would need to involve liquid
chromatography mass spectrometry in addition to MADLI-MS followed by tandem mass
spectrometry (LC-MALDI MS and MS/MS). Initial separation of proteins using LC
increases sensitivity and selectivity when compared to MALDI alone. Because the goal is
to identify endogenous proteins bound to chromatin following DNA damage, it is likely
that the increased sensitivity of LC-MALDI MS would be needed to help capture many
of the low abundant NER proteins in the complex. It is hoped that these future
experiments would help to construct a more detailed view of PARP-1’s role in NER.
5.4.

Significance
Gaining a more complete understanding of PARP-1 in DNA repair pathways has

broad implications. Currently, PARP’s function in BER is being utilized to treat cancer.
More specifically, PARP inhibitors are being used to act as sensitizers to DNA damaging
chemotherapy or radiation (Telli and Ford, 2010; Tentori et al., 2002). PARP inhibitors
show enhanced chemopotentiation when used in combination with methylating agents
(i.e. temozolomide, TZM) and topoisomerase inhibitors (Drew and Plummer, 2009;
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Megnin-Chanet et al., 2010). Additionally, they show enhanced cytotoxcity when in
combination with radiotherapies (Dungey et al., 2008; Megnin-Chanet et al., 2010).
Another strategy for the use of PARP inhibitors is in genetically susceptible cells.
In this case, cell populations that already harbor altered DNA repair pathways in
combination with PARP inhibitors result in synthetic lethality, where loss of function of
two genes leads to cell death. This is a common strategy in cells with BRAC1 and
BRAC2 mutations. These cells have defective homologous recombination (HR)
pathways. When a PARP inhibitor is administered the repair of endogenous single-strand
breaks (SSBs) is decreased leading to persistent SSBs which are converted to double
strand breaks (DSBs) at replication forks. Cells with functioning HR can repair the breaks
and survive, but BRCA1/BRAC2 deficient cells cannot repair the DSBs and are
susceptible to the lethality of PARP inhibitors (Helleday, 2011; Kummar et al., 2012;
Ratner et al., 2012; Telli and Ford, 2010). This use of PARP inhibitors takes advantage of
PARP’s role in BER.
Based on the novel results presented in this dissertation there is the potential for
therapeutic application of PARP function in NER. Ideally, this new information could be
useful with drugs and/or compounds known to cause damage repaired by NER. A class of
potential candidates includes the numerous platinum (Pt)-based chemotherapeutics such
as cisplatin, carboplatin and oxaliplatin. These drugs intercalate into the cell forming
various DNA lesions which eventually inhibit DNA replication leading to cell death.
There are three main lesions formed as a result of platinum exposure: monoadducts,
intrastrand crosslinks and interstrand crosslinks. These lesions bend the DNA double
helix toward the major groove creating bulky DNA lesions (Di Francesco et al., 2002).
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Platinum lesions can be recognized and repaired by NER, mismatch repair or
homologous recombination (HR). Given the structure and ability of platinum lesions to
distort the DNA helix and obstruct transcription and replication, NER is the most
important repair pathway in the efficacy of platinum chemotherapy (Danford et al., 2005;
Rabik and Dolan, 2007). Administration of PARP inhibitors in combination with
platinum drugs would be predicted to decrease lesion repair and increase DNA damage
potentially leading to cell death.
In conclusion, the data presented throughout this dissertation advances the current
knowledge regarding the contributions of PARP in NER. It not only provides a novel
mechanism regarding interactions between PARP and important NER proteins but also
showcases the importance of PAR in this pathway. As such, this data opens the door to
possibly expand the knowledge and use of therapies involving PARP inhibition. More
specifically, this work could have broad implication in cancer chemotherapy.
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APPENDIX A: PARP inhibition and its effects on XPA nuclear
localization
Introduction
UVR exposure has been reported to increase nuclear localization of XPA through
a mobilized fraction of the protein (Shell et al., 2009; Wu et al., 2007). In an effort to
observe this aspect of XPA function we investigated if there were any changes to its
localization under conditions of PARP activation and PARP inhibition.
Results
Within our system, there was no change to total XPA (Fig. A.1A and A.1B) over
a 6 hour time period following UVR, but there was a significant increase in nuclear XPA
one hour post exposure (Fig. A.1D). This data was confirmed using colocalization
techniques. Quantification of nuclear XPA showed a significant increase following
exposure to UVR alone (Fig. A.2A, UV). A pharmacologic inhibitor of PARP, DPQ, was
used to probe the impact of PARP activity on XPA localization. The observed UVRinduced increase in nuclear XPA was diminished in cells treated with DPQ (Fig. A.2A,
DPQ+UV). Biochemical analysis of subcellular fractions obtained from cells exposed to
UVR in the absence or presence of DPQ confirmed the results obtained by colocalization
techniques (Fig. A.2B, UV and DPQ+UV). These findings illustrate that PARP activity
may regulate nuclear localization of XPA.
Discussion
The data presented in Appendix B strengthens the results presented in Chapter 2,
Fig. 2.7 which shows functional changes to XPA chromatin binding following PARP
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inhibition. Overall, the combination of these data illustrate that PARP activity may be
important in the regulation of NER proteins which could contribute to the retention of
UVR-induced photolesions following PAPR inhibition.
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FIGURE A.1. Changes in XPA localization following UVR exposure. HaCaT cells were given a single dose
of ssUVR (3 kJ/m2) and whole cell extracts (WCE) were collected at various times post exposure. A,
Representative western blot showing total XPA protein over time following UVR exposure. B, Quantification
of (A) by densitometry. GAPDH was used as a loading control. XPA intensity was normalized to NT. Data
presented as means ± SEM, n=6. HaCaT cells were given a single dose of ssUVR (3 kJ/m 2) and nuclear
fractions were collected at various times post exposure. C, Representative western blot showing XPA in the
nuclear fraction following UVR exposure. PARP-1 and β-tubulin were used as controls for nuclear and
cytoplasmic fractions, respectively. D, Quantification of (C) by densitometry. XPA intensity was normalized to
NT. Data presented as means ± SEM, n=4. **p<0.01.
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FIGURE A.2. PARP inhibition and its effects on XPA nuclear localization. HaCaT cells were pre-exposed
to a PARP inhibitor, DPQ, 30 minutes prior to UVR exposure. They were subsequently fixed one hour post
exposure. A, Graph representing quantification of fluorescent images where colocalization between XPA and
DAPI (Nuclear XPA) were calculated. Data normalized to NT sample. Data presented as means ± SEM, n=4.
Significance compared to NT. B, Graph representing XPA protein in nuclear and cytoplasmic fractions
obtained from HaCaT cells. Data represents densitometry obtained from western blots. Data presented as
means ± SEM, n=3. Significance compared to NT. * p<0.05, **p<0.01.
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APPENDIX B: PARP-1 and DDB1
Introduction
The paper published by Gagne et al. identified hundreds of proteins predicated to
associate with PAR (Gagne et al., 2008). From this report we investigated the protein
XPC and found it to associate with PAR following UVR-exposure (Chapter 3, Fig. 3.1).
Additionally, we were able to observe that XPC was part of a complex with automodified
PARP-1 that is dependent on PAR formation (Chapter 3, Fig. 3.2). An additional NER
protein identified within this paper was the DNA damage binding protein 1 (DDB1).
DDB1 is associated with lesion recognition of both CPDs and 6-4 PPs (Sugasawa, 2009;
Wakasugi et al., 2002). In the case of CPDs, Sugasawa et al. and others have proposed a
model where DDB binds first to CPDs and then recruits XPC to the damaged site (Fitch
et al., 2003; Sugasawa, 2006). This is important for CPD repair because they tend to
distort the DNA helix less than 6-4 PPs (Rastogi et al., 2010). A functional experiment
within the Gagne et al. paper confirmed that DDB1 was able to be immunoprecipitated
using antibodies specific to PAR (Gagne et al., 2008). To expand on this data we
investigated if DDB1 might form a complex with automodified PARP-1.
Results
HaCaT cells were exposed to UVR and whole cell extracts were collected at
various times post exposure. Using these samples, antibodies specific to PARP-1 were
used for immunoprecipitation. Co-immunoprecipitation methods were performed to see if
there was an association between PARP-1 and DDB1 following UVR exposure. We
observed a significant increase in the association between PARP-1 and DDB1 at all times
post UVR-exposure (Fig. B.1A and B.1B). Similar to XPA (Chapter 2) and XPC
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(Chapter 3) we wanted to investigate the importance of PAR formation in the association
between PARP-1 and DDB1. We conducted experiments using the PARP inhibitor AG014699 to reduce the levels of cellular PAR. We observed an increased association
between DDB1 and PARP-1 five minutes post UVR-exposure (Fig. B.1D). Following
PARP inhibition we did not see a significant change in association between PARP-1 and
DDB1 as noted with other NER proteins (XPA and XPC). Overall, these data show that
there is a UVR-induced increase in the association between PARP-1 and DDB1 but it
may not rely on PAR formation.
Discussion
The data obtained for DDB1 differs from what we observed for XPA and XPC.
The association between other NER proteins (XPA and XPC) and PARP-1 was found to
be dependent on PAR formation. On the contrary, there was no change in DDB1 binding
to PARP-1 following PARP inhibition. This may be due to the time point used. These
experiments were performed five minutes post UVR-exposure. While Fig. B.1B showed
a significant association at this time point, this data was not reproducible as seen in Fig.
B.1D. Experiments performed 30 minutes post UVR-exposure may provide a better
picture of the association between PARP-1 and DDB1. Additionally, this data could be
indicating that there is a direct interaction between PARP-1 and DDB1 as opposed to a
PAR-enhanced interaction. Additional biochemical experiments will need to be
conducted to better understand the nature of the interaction between PARP-1 and DDB1.
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FIGURE B.1. PARP inhibition does not affect the association between PARP-1 and DDB1. HaCaT cells were
given a single dose of ssUVR (3 kJ/m2) and collected at various times post exposure. A, Representative image of coimmunoprecipitation. PARP-1 was immunoprecipitated (IP) from cells and membranes were subsequently
immunoblotted (IB) for DDB1. Membranes were stripped and immunoblotted for PARP-1, as confirmation for
immunoprecipitation. B, Quantification of DDB1 western blot from (A) by densitometry. Data presented as means ±
SEM, n=4. C, HaCaT cells were pre-exposed to the PARP inhibitor, AG-014699, 1 hour prior to UVR exposure and
collected five minutes post exposure. Representative image of co-immunoprecipitation. PARP-1 was
immunoprecipitated (IP) from cells and membranes were subsequently immunoblotted (IB) for DDB1. D,
Quantification of DDB1 western blot from (C) by densitometry. Data presented as means ± SEM, n=4. *p < 0.05. ***
p < 0.001.
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